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 The interest in the opioid/orphanin gene family stems from functional similarities 
that these peptides have to the narcotic opium. Opiates have been extensively studied 
because of their analgesic properties; however, the reason that these plant produc s can 
affect the human central nervous system was a mystery until the discovery of opiate-like 
peptides. The endogenous opioid peptides are well understood today because they have 
been fully cloned and characterized in several different organisms including lower 
chordates. On the other hand, the opioid/orphanin receptors have not been fully cloned or 
characterized in lower chordates; therefore, to better understand the past and present 
evolutionary path of the opioid/orphanin gene family it is important to have opioid 
receptor sequence information available over a broad taxonomic scale in lower chordates. 
This study reveals opioid/orphanin receptor sequence from Petromyzon marinus 
(lamprey), Heterodontus francisci (horn shark), and Acipenser transmontanus (white 
sturgeon). This sequence information exposed the conservation of critical amino acids 
within the opioid binding pocket and disulfide bridge, uncovered the possibility of crucial 
amino acids involved in ligand selectivity, and offered a proposed hypothesis for the 
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1. Discovery of Opiates 
The interest in the opioid/orphanin gene family stems from functional similarities 
that these peptides have to the narcotic opium. Opium is an alkaloid derived from the 
opium poppy Papaver somniferum L.; a colorful flower harvested all over the world 
(Corbett et al, 2009). There are many alkaloid constituents that can be extracted from the 
opium poppy including morphine, noscapine, codeine, and thebaine. Opiates have been 
extensively studied because of their analgesic properties; however, the reason that these 
plant products can affect the human central nervous system was a mystery (Aggrawal, 
1995) until the discovery of opiate-like peptides (Hughes et al., 1975).    
 
2. Overview of Opioid Ligands and their Precursors 
 The first opioid peptides isolated from pig brain were the enkephalins. They are 
composed of two pentapeptides with amino acid residues H-Tyr-Gly-Gly-Phe-Met-OH 
(YGGFM) and H-Tyr-Gly-Gly-Phe-Leu-OH (YGGFL). These peptides were termed 
Methionine-enkephalin (Met-Enk) and Leucine-enkephalin (Leu-Enk), respectively 
(Hughes et al., 1975). Larger opioid peptides were later discovered that contained either a 
Met-Enk or Leu-Enk sequence as their core fragment (Kakidani et l., 1982). Isolated 
from camel pituitary extracts, β-endorphin (β-End) is a C-terminally extended form of 
Met-Enk with an additional 26 amino acids at the carboxyl end (Table 1) (Li and Chung, 
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1976). As the isolation of dynorphins began, two more hypothalamic opioid peptides with 
Leu-Enk core fragments at their amino-terminals were revealed; a decapeptide termed α-
neoendorphin with a five amino acid carboxy-terminal extension and a nonapeptide 
termed β-neoendorphin with a four amino acid carboxy-terminal extension. (Table 1) 
(Kangawa et al. 1979, 1981; Minamino et al., 1981). Finally two additional opioid 
peptides isolated from porcine and bovine pituitary were discovered; Dynorphin A (Dyn 
A) a heptadecapeptide with a Leu-Enk core fragment and 12 amino acid carboxy-terminal 
extension (Goldstein et al., 1979 & 1981) and Dynorphin B (Dyn B) a tridecapeptide 
with a Leu-Enk core fragment and an eight amino acid carboxy terminal extension (Table 
1) (Fischli et al., 1982; Kilpatrick et al., 1982)  
These biologically active opioid peptides were found to be derivatives of larger 
protein precursors due to post-translational processing (Hughes et al., 1980). This post-
translational processing was thought to involve trypsin-like proteolytic cleavage at 
characteristic sites with paired, basic amino acids that flank the biologically a tive opioid 
sequence as shown in Figure 2 (Steiner et al., 1974; Steiner, 1976). Subsequent studies 
implicated their serine proteases prohormone convertase I and prohormone convertase II 
as the enzymes involved in the endoproteolytic cleavage of opioid precursors (Seidah et 
al., 1999).  It has now been shown that the opioid peptides are encoded by three distinct 
prohormone precursors, proenkephalin (Pro-Enk), proopiomelanocortin (POMC), and 
prodynorphin (Pro-Dyn). Pro-Enk cDNA’s were cloned by Noda et. al (1982) revealing 
one Leu-Enk and four Met-Enk sequences. Cleavage of POMC has been shown to 
produce β-End, adrenocorticotropic hormone (ACTH), and α-melanocyte stimulating 
hormone (α-MSH) (Nakanishi et al., 1979). Pro-Dyn cleavage produces dynorphin A, 
3 
dynorphin B, α-neoendorphin and β-neoendorphin (reviewed in Dores et al., 1993). 































Amino Acid Sequences of Opioid Peptides 
Methionine-enkephalin (Met-Enk) YGGFM 
Leucine-enkephalin (Leu-Enk) YGGFL 





Dynorphin A (Dyn A) 
Dynorphin B (Dyn B) 






Table 1. Amino acid sequence of each opioid peptide discussed in the text. The italicized 
letters represent the core fragment for each peptide. The bold letter represents a 
























Figure 1. Structure of Precursor Proteins 
Schematic structure of each precursor gene with their characteristi cy eine-rich amino-
terminus and paired, basic amino acids which flank the biologically active opioid 
sequence (Dores et al, 1993). The line above α-n oendorphin represents amino acid 
residues 1-10 while the line above β-neoendorphin represents amino acid residues 1-9 





3. Opioid Receptors in Mammals 
In the early 1970’s, almost in parallel to the discovery of endogenous opioid 
ligands, binding studies using radiolabelled opioid ligands revealed the presence of 
opioid receptors (Pert and Snyder, 1973; Simon et al., 1973; Terenius, 1973). Martin and 
colleagues proposed that there were three receptors types based on studies that showed 
different pharmacological effects in response to several morphine- and nalorphine-like 
drugs administered to the chronic spinal dog. The receptors were named according to the 
drug that elicited the syndrome; Morphine interacted with the mu (µ) opioid receptor 
(MOR), Ketocyclazocine interacted with the kappa (κ) opioid receptor (KOR), and SKF-
10,047 (N-allylnormetazocine) interacted with the sigma (σ) opioid receptor (Martin et. 
al, 1976; Gilbert et. al, 1976). It was later shown that the σ-opioid receptor was not a true 
opioid receptor because the opioid antagonist naloxone was unsuccessful in antagonizig 
the binding and in vivo effects of N-allylnormetazocine and related benzomorphan 
alkaloids (Mannalack et al., 1986). In 1977 Lord and colleagues discovered that the 
action of the enkephalins in mouse vas deferens acted on a different receptor than the
receptors that morphine and morphine-like agonists act because 10 times more naloxone 
was required for the successful antagonism of enkephalins than for that of normorphine; 
this new receptor was designated delta (δ) opioid receptor (DOR) (Lord et al., 1977; Lord 
et al., 1976). Therefore, the three classic opioid receptors presently found in mammals are 
MOR, KOR, and DOR.  
 Although these three classic receptors can bind to several different endogenous 
opioid ligands produced by the three prohormone precursors mentioned earlier, they also 
have specific ligands that they bind to preferentially. Ligand selectivity is based on the 
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post-translational processing of the peptide revealing that two opioid recognition cores 
are responsible for binding the three receptors MOR, DOR, and KOR.  The YGGFM or 
YGGFL core is required and adequate for binding DOR and MOR while an arginine 
extension to this core, YGGFMR or YGGFLR, is required and adequate for KOR 
binding. The shorter Pro-Enk products bind with the greatest affinity to DOR, but the C-
terminally extended enkephalins bind to all three receptors with a high affinity. POMC 
products such as β- endorphin have an equal affinity for both DOR and MOR but low 
affinity for KOR. KOR demonstrates the maximum level of ligand selectivity of all three 
receptors binding with the highest affinity to Pro-Dyn products. However Pro-Dyn 
products can also bind to MOR and DOR (Mansour et al., 1995). Figure 3 demonstrates 
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Table 2. Receptor/Ligand Binding Relationships 
Arrows represent receptor/ligand binding with an upward arrow (↑) symbolizing 
strong/high affinity, a downward arrow (↓) symbolizing poor/low affinity, and no arrow 
symbolizing no receptor/ligand binding. C-terminally extended enkephalins bind MOR, 
DOR, and KOR with high affinity, but do not bind ORL-1. Although dynorphins bind 
MOR and DOR, they bind KOR with the greatest affinity and do not bind ORL-1 at all. 
β-endorphin binds MOR and DOR with equal affinity, KOR with low affinity, and does 
not bind ORL-1. Orphanin FQ binds only to ORL-1 (Mansour et al., 1995).  Kd values 





In the search for other members of the opioid receptor gene family, Mollereau and 
colleagues isolated an orphan receptor from a human cDNA library encoding Opioid 
Receptor Like 1 (ORL-1). The receptor protein consisted of 370 amino acids and 
demonstrated high sequence identity to that of the other three classical opioid recepto s 
(Mollereau et al., 1994). This same receptor was later independently isolated from murine 
clones (Bunzow et. al, 1994; Fukuda et al., 1994; Lachowicz et al., 1995; Nishi et al., 
1994; Wang et al., 1994; Wick et al., 1994) and showed ~65% sequence homology to 
each of the other three opioid receptors. This is consistent with the sequence homology 
between any of the two classical opioid receptors which is about 70% in mammals (Chen 
et al., 1994). The pharmacological effects exerted by this newly discovered orphan 
receptor did not resemble any of the effects exerted by the previously isolated 
endogenous opioid ligands or any of the opioid receptor agonists; this led two separate 
groups to isolate the endogenous ligand for ORL-1. Using reverse pharmacology (Libert,
F. et al., 1991), based on the identification of the ORL-1 receptor, they discovered a 
heptadecapeptide called nociceptin/orphanin FQ (N/OFQ) that closely resembl d 
dynorphin A with the amino acid sequence FGGFTGARKSARKLANQ (Table 1) 
(Meunier et al. 1995; Reinscheid et al., 1995). The partial cDNA isolated from rat-brain 
library encodes this ligand flanked by Lys-Arg proteolytic cleavage motif which is 
consistent with the other opioid ligands described earlier (Meunier et al., 1995). This 
partial cDNA sequence suggests that N/OFQ is processed from a larger protein ecursor 
just as the previously described opioid ligands were. This precursor protein named
prepronociceptin (PPNOC) was later fully sequenced and characterized from human, 
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mouse, and rat; it was found to be most similar to POMC in that PPNOC encodes a single
copy of N/OFQ (Mollereau et al., 1996). The discovery of ORL-1, its endogenous ligand, 
and the complete protein precursor, from which it is biologically processed, comprises 
the opioid/orphanin gene family. Molecular cloning of cDNA’s for each of the four 
receptors has shed light on their pharmacology, distribution, and structure. 
 
3.1 Structural Characteristics of Opioid Receptors 
 Hydropathy analyses of the cloned receptor sequences revealed that opioid 
receptors are G-protein coupled receptors (GPCR’s) characterized by seven 
transmembrane-spanning domains (Figure 2). In mammals, the receptors show the 
highest sequence identities to each other within the transmembrane regions (41%-76%) 
and intracellular regions (59%-89%). The extracellular regions are the most diverse 
sharing only 6%-7% sequence identity with the exception of the first extracellul r loop. 
(Table 3). The formation of a disulfide bridge between cysteine residues in the first and 
second extracellular loop seems to be essential in stabilizing the functional receptor 
protein structure. Increasing levels of reducing agents such as dithiothreitol (DTT) break 
down disulfide bridges and cause the opioid receptor to become increasingly more 
asymmetrical which inhibits opioid agonists from binding to the receptor molecule 
(Gioanniani et al., 1989; Fawzi et al., 1997). Another structural characteristic of opioid
receptors is N-linked glycosylation sites within the N-terminal domain; ech receptor has 
anywhere from two to five glycosylation sites within its N-terminus (reviewed in Satoh & 
Minami, 1995) (Figure 2). These glycosylation sites could be important in the binding 










Figure 2: Structure of Opioid Receptors 
Opioid receptors have seven transmembrane-spanning (TM1-7) domains within the 
plasma membrane, three extracellular loops (EL 1-3) on the N-terminus side, and three 
intracellular loops (IL 1-3) on the C-terminus side. They are most highly conserved 
within the TM regions and the IL regions. They show high diversity within the EL 
region. The disulfide bridge between the cysteines (red circles) in the first and second 
extracellular loop is consistent between all four receptors. The green dots repre ent 



















Amino Acid Sequence Identity Among Human, 
 Rat, and Mouse Opioid Receptors 
                  ______________________________________________________ 
                                                                                ___Amino Acid % Identity_ 
                 _________________________________hOR         rOR____mOR _ 
                      
                         Extracellular (EC) Regions                   
1st EC Loop    50            50            50   
 2nd EC Loop    7              7              7 
   3rd EC Loop    6              6              6 
 
                          Transmembrane (TM) Regions 
   TM1     42       44            44  
      TM2     74             70            70 
   TM3                73             73            73 
   TM4     23             23            23 
   TM5     54             58            58 
   TM6     41             41            41 
   TM7     76             73            73 
 
               Intracellular (IC) Regions 
   1st IC Loop    89             78            78 
   2nd IC Loop    59             59            59 
   3rd IC Loop    78             74            74 
 
 
Table 3. This table shows the sequence identity between all four receptors (DOR, MOR, 
KOR, and ORL-1) in human (hOR), rat (rOR), and mouse (mOR). Each receptor was 
aligned (using ClustalW ) at the amino acid level for each organism and the sequenc  
identity was based on identical residues among all four receptors. The sequences for each 
mammal can be found in the NCBI database using the following accession numbers: 
MMOR: NM_001039652, MORL1: NM_011012, MKOR: NM_011011, MDOR: 
NM_013622, HMOR: NM_001145282, HKOR: NM_000912, HDOR: NM_000911, 
HORL1: NM_182647, RDOR: NM_012617, RKOR: NM_017167, RMOR: 
NM_001038601, RORL1: NM_031569. Abbreviations are as follows: M = mouse, H = 





3.2 Function and Distribution of Opioid Receptors 
Opioid receptors couple to G proteins, GDP is replaced with GTP disassociating 
the alpha subunit which inhibits adenylyl cyclase and decreases cAMP within the cell. 
The beta-gamma subunit closes voltage-gated Ca2+ ch nnels and activates inwardly 
rectifying K+ channels as shown in Fig 2 (reviewed in Kreek and LaForge 2007 and 
Dhawan et al., 1997). Activating inwardly rectifying K+ channel leads to a 
hyperpolarization, which will decrease the release of excitatory neurotransmitters 
(Endogenous Opioid Systems); this is referred to as antinociception.  Although all three 
of the classic opioid receptors play a role in analgesia, each receptor also has sever l 
different functions that they exhibit based on their distribution within the central ne vous 
system (CNS). Studies done in mammals including rat, mouse, and guinea pig revealed 
the distribution and function of each receptor. 
The kappa opioid receptor is involved in nociception, diuresis, feeding, 
neuroendocrine secretions (Hansen and Morgan, 1984), dysphoria (Pfeiffer et al., 1986), 
miosis and respiratory depression (www.Opioids.com). KOR receptors are found within 
the inner layers of the cerebral cortex, substantia nigra, interpeduncular nucleus, nucleus 
accumbens, claustrum, and dorsal endopiriform nucleus (reviewed in Dhawan et al., 
1996) 
The delta opioid receptor plays a role in respiratory depression, gastro-intestinal 
motility, olfaction, cognitive function, analgesia, mood driven behavior, and motor 
integration. The olfactory bulb, neocortex, caudate putamen, and nucleus accumbens 
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show the highest density of DOR, while the thalamus, hypothalamus and brainstem 
illustrate moderate to low DOR densities (reviewed in Dhawan et al., 1996) 
MOR is highly important in antinociception, blocking nociceptive responses to 
mechanical, thermal or chemical high intensity stimulations (Knapp et al., 1989). 
Stimulation of MOR has been shown to lead to depression of respiration, cardiovascular 
functions, intestinal transit, feeding, learning and memory, locomotor activity, 
thermoregulation, and immune functions. MOR are scattered throughout the neuraxis 
with the highest density found in the caudate putamen. MOR’s are also present in the 
neocortex, thalamus, nucleus accumbens, hippocampus, amygdale, periaqueductal gray, 
raphe nuclei and superficial layers of the dorsal horn. The lowest density of MOR’s are 
expressed in the hypothalamus, preoptic area, and globus pallidus (reviewed in Dhawan 
et al., 1996) 
ORL-1 receptors are expressed in several different regions of the CNS, but 
especially within the brainstem, limbic areas, hypothalamus, and spinal cord (Mollereau 
et al., 1994). Because of its distribution within the CNS it is thought that ORL-1 may be 
involved in learning and memory, homeostasis, attention and emotions, and sensory 
perception. Once the endogenous ligand was discovered, it was shown that stimulation of 
ORL-1 caused an increased reactivity to pain (Meunier et al., 1995) 
Because each of the opioid receptors are involved in a number of  biological 
processes, it is imperative to study the phylogeny of these receptors in all of the major 
groups of vertebrates rather than making generalizations about structure/f nction 





                                                                   
Figure 3: Schematic diagram of opioid receptor signaling based on µ-opioid receptor 




4. Opioid Receptors in Non-Mammalian Vertebrates    
 To better understand the past and present evolutionary path of the opioid/orphanin 
gene family it is important to have opioid receptor sequence information available over a 
broad taxonomic scale in lower vertebrates. The endogenous opioid ligands are well 
understood today because they have been fully cloned and characterized in several 
different organisms including lower vertebrates. This led to the discovery that opioid 
peptides had undergone several duplication events throughout their evolution (Dores et 
al., 1993). These duplications allow for mutations within each duplicated gene, which in 
turn permits different functionality within at least one of the gene duplicates (Danielson 
& Dores, 1999).  This same concept is thought to be applied to the opioid receptor 
family. The opioid receptors however are not fully understood because extant 
representatives from the earliest class of vertebrates have yet to be fully cloned with the 
exception of zebra fish. To resolve this problem, attempts to fully clone the four opioid 
receptors from lamprey, horn shark, and white sturgeon are undertaken. This sequence 
information will give insight into the order in which each opioid receptor arose, help to 
identify ancient structural elements that may be essential for opioid receptor function, and 
later down the line will elaborate on the recent discoveries surrounding the differ nces in 
receptor binding affinity and signaling properties between non-mammalian vertebrates 




Materials and Methods 
1. Animals 
White Sturgeon 
 Sexually immature white sturgeons, Acipenser transmontanus were obtained from 
Oregon State University (courtesy of Dr. Carl Shreck). Sturgeons were anesthetized by 
prolonged immersion in MS-222 (Sigma, St Louis, MO) and were sacrificed by 
decapitation. Their brains were rapidly removed and either placed in RNA Later 
(Ambion, Austin, TX) and stored at -20C or flash frozen in liquid nitrogen and stored at  
-80C until RNA isolation. 
Horn shark 
 Horn sharks, Heterodontus francisci were collected at the Scripps Institute (San 
Diego, CA). The animals were anesthetized by lowering their body temperature to 10ºC 
They were then decapitated; their brains were removed and immediately placed on dry 
ice. The brain samples were stored at -80ºC until RNA isolation. 
Lamprey 
Lampreys, Petromyzon marinus, were obtained from http://lampreyservices.com. 
Lampreys were anesthetized by prolonged immersion in MS-222 (Sigma, St Louis, MO) 
and were sacrificed by decapitation. Their brains were rapidly removed and either placed 
in RNA Later (Ambion, Austin, TX) and stored at -20C or flash frozen in liquid nitrogen 
and stored at -80C until RNA isolation. 
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2. Total RNA Extraction 
The RNA extraction protocol used was developed by the W.M. Keck Foundation 
Biotechnology Microarray Resource Laboratory at Yale University. 50mg of previously 
extracted white sturgeon, Lamprey, and Horn shark brain were homogenized in 1mL of 
TRIzol reagent using a glass dounce. The samples were centrifuged for 90 seconds at 
room temperature to remove any non-homogenized debris and the supernatant was 
transferred to a fresh eppendorf tube, where they were incubated for five minut s at room 
temperature. 200µl of chloroform was added, the tube was shaken by hand vigorously for 
15-30 seconds and then incubated for three minutes at room temperature. Centrifugation 
took place at 12,000g for 15 minutes at 2-8ºC. The RNA remained in the upper aqueous 
phase and was transferred to a fresh eppendorf tube. 500µl of Isopropyl alcohol was 
added, the tubes were vortexed for 10 seconds and incubated at room temperature for 10 
minutes. Centrifugation took place at 12,000g for 10 minutes at 2-8ºC. The supernatant 
was removed by aspiration and the RNA pellet was washed once with 75% ethanol and 
vortexed. Centrifugation took place at 7,500g for five minutes at 2-8ºC. The supernatant 
was once again removed by aspiration and the RNA pellet was air-dried for 10 minutes. 
The RNA pellet was rehydrated in 22µl RNase-free water.  
 
3. Chloroform Extraction  
 A chloroform clean-up was performed on the total RNA to extract the remaining 
phenol left from the TRIzol extraction. An equal amount of chloroform was added to the 
rehydrated samples, they were mixed by inverting five times and centrifuged at full speed 
for 5 minutes. The upper aqueous layer was transferred to a fresh eppendorf tube and 
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one-tenth of the total volume of NaOAc was added along with 3 times the total volume of 
100% ethanol. Centrifugation took place at full speed for 10 minutes at 2-8°C. The 
supernatant was removed by aspiration and the pellet was washed with 70% ethanol (the 
volume used was half the total volume of the eppendorf tube) and centrifuged at room 
temperature for five minutes at full speed. The supernatant was removed once agai  by 
aspiration and the pellet was air-dried for ten minutes. The purified RNA pellet was 
rehydrated in 22µl of RNase-free water.  2µl of the purified total RNA product was 
analyzed using a Nanodrop ND1000. A 1.8 or higher 260/280 ratio was obtained each 
time. The 230/260 ratio was 2:1 or higher 
 
4. Reverse Transcription 
 The total RNA products underwent reverse transcription using the Superscript III 
First-Strand Synthesis System for RT-PCR (Invitrogen, Carslbad, CA). At least 1µg of 
total RNA was used in conjunction with the reverse transcription primer Anchor-dT17 
(5’GAC TCG AGT CGG ATC CAT CGA T173’), which bound its seventeen thymine 
residues to the complementary poly-A tail of mRNA transcripts. The first strand of 
cDNA for all three species was then used in a polymerase chain reaction (PCR).
 
4.1 RT-PCR 
 A forward degenerate primer designed by Li et al. (1996): OpR-Fwd 
(5’GAARACIGCIACIAAYATHTA3’) and a degenerate reverse primer: JMDR 
(5’DATNTGDATNGGNGTCCARC3’) were targeted to two highly conserved regions 
among all four opioid/orphanin receptors in zebrafish. The forward primer was targeted 
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to the sequence KTATNIY, found just outside and within the second transmembrane 
spanning region (TM2). The reverse primer was targeted to the sequence CWTPI(H,Q)I, 
found within the sixth transmembrane spanning region(TM6). This primer set was used 
on all three species and additional homologous primers were designed for the lamprey 
only (Figure 4). 
Gene-specific forward and reverse primers were designed for each of the f ur 
receptors obtained from the lamprey genome. For the lamprey receptor 1A, a forward 
primer: LR.1A.Fwd (5’-AAAACCGCCACCAACAT-3’) and reverse primer: LR.1A.Rev 
(5’-CCAGCACACCACGAAG-3’) were targeted to the sequences KTATNI, within the 
first intracellular loop (ICL1), and AFVVCW within TM6 (Figure 5a). The 1B receptor 
forward primer: 1B.Fwd (5’-ACCGCTACCAACATCTAC-3’) was targeted to the 
sequence TATNIY, found between ICL1 and TM2, and the 1B reverse primer: 
LR.1B.Rev (5’-ACGTTGATGAGCTTGGC-3’) was targeted to the sequence AKLINV, 
found at the beginning of TM4 respectively (Figure 5b). A degenerate forward primer: 
LR.Degen.Fwd (5’-ARACSGCYACMAACAYBTAY-3’) and a gene-specific revers  
primer: LR.2A.Rev (5’-GATAGACGAGAGCAGCC-3’) were used to target sequ nces 
within the lamprey 2A receptor. The 2A forward primer was targeted to the sequ nce 
KTATNIY found between ICL1 and TM2 while the 2A reverse primer was targeted to 
the sequence WLLSSI found within TM4 (Figure 5c). Finally, the 2B forward primer: 
2B.Fwd (5’-GAAGACGGCTACCAACACG-3’) was targeted to the sequence KTATNT, 
found between ICL1 and TM2, and the 2B reverse primer: LR.2B.Rev (5’-
TTCTTGGCCGTGCCC-3’) was targeted to the sequence GTAKK, found at the end of 
TM4 (Figure 5d). 
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The PCR reagents were as follows: 2µl of each primer at 10µM each, 2µl of 
10mM dNTP mix, 2µl of 10X PCR buffer (100mM Tris pH9.2, 750mM KCl, and 35mM 
MgCl2), 9.8µl of dH2O, 0.2µl of Taq polymerase at 5U/µl (Invitrogen, Carlsbad, CA) and 
2µl of first strand cDNA template. The thermal profile allowed an initial pre-heat at 94ºC 
for three minutes followed by 32 cycles, each cycle consisting of a forty-five second 
denaturing step at 94ºC followed by an annealing step at 46.7ºC for thirty seconds and an 
extension step at 72ºC for one minute and a half. A final step at 72ºC for ten minutes 
































































































Figure 4: Schematic diagram of the structure of opioid receptors based off of the MOR 
sequence from rat. The red bold circles indicate the sites where the forward and reverse
degenerate primers were targeted for white sturgeon and horn shark. The forward 
degenerate primer designed by Li et al. was targeted to the amino acid sequence 
KTATNIY. The reverse degenerate primer was targeted to the amino acid sequence 
CWTPI(H,Q)I. The arrows represent the direction in which the primers were designed to 
work. Each transmembrane domain is clearly labeled as well as the extracellular space, 
































Figure 5a: Lamprey Opioid Receptor 1A  
 
     1 GTACACCAAGATGAAAACCGCCACCAACATTTATATCTTCAACCTGGCTCTGGCCGACAC 
     1 -Y--T--K--M--K--T--A--T--N--I--Y--I--F--N--L--A--L--A--D--T 
          
    61 GCTGGCCACCAGCACCCTGCCCTTCCAGATTGTCAACTACTTCATGAGCACATGGCCCTT 
    20 --L--A--T--S--T--L--P--F--Q--I--V--N--Y--F--M--S--T--W--P--F 
 
   121 CGGTCGCGTCCTCTGCAAGCTCATCATCTCCATAGACTATTATAACATGTTCACGAGCAT 
    40 --G--R--V--L--C--K--L--I--I--S--I--D--Y--Y--N--M--F--T--S--I 
 
   181 CTTCACGCTCACCATGATGAGCATCGACCGATACATCGCCGTGTGCCACCCGGTGAGGGC 
    60 --F--T--L--T--M--M--S--I--D--R--Y--I--A--V--C--H--P--V--R--A 
 
   241 GCTGGATTTCCGAACGCCCGTCAAGGCCAAGCTCGTTAATATCTGCATCTGGTCGCTGTC 
    80 --L--D--F--R--T--P--V--K--A--K--L--V--N--I--C--I--W--S--L--S 
 
   301 ATCTGCCATCGGCCTGCCCGTCATGATCATTGCGGTGACCAAGCAGGATAAGAACGAGAG 
   100 --S--A--I--G--L--P--V--M--I--I--A--V--T--K--Q--D--K--N--E--R 
 
   361 GACACACACTTGCGTCGCTGATGAACTGCCCGTATTTCCCCGTGCCGCAGGCAACGTGGA 
   120 --T--H--T--C--V--A--D--E--L--P--V--F--P--R--A--A--G--N--V--D 
 
   421 CTGCACGCTGGAGTTCCCCATCTACTGGGACAACATGCTGAAGACGTGCGTGTTCGTGTT 
   140 --C--T--L--E--F--P--I--Y--W--D--N--M--L--K--T--C--V--F--V--F 
 
   481 CGCCTTCTTCATCCCCGTGTGTGTCATCACCGTCTGCTATGGCCTCATGATCACGCGCCT 
   160 --A--F--F--I--P--V--C--V--I--T--V--C--Y--G--L--M--I--T--R--L 
 
   541 GCGCAGCGTGCGCGTGCTCTCGGGCTCCAAGGAGAAGGACCGCACCATGCGGCGCATCAC 
   180 --R--S--V--R--V--L--S--G--S--K--E--K--D--R--T--M--R--R--I--T 
 
   601 ACGCATGGTGCTCGTCGTGGTGGCCGCCTTCGTGGTGTGCTGGACGCCTATCCACCTGTA 
   200 --R--M--V--L--V--V--V--A--A--F--V--V--C--W--T--P--I--H--L--Y 
                                 
   661 CGTCATCGTCCGCGCCATCGTGCGAATCCCCGAGAGCGCCGTCGTGACG 
   220 --V--I--V--R--A--I--V--R--I--P--E--S--A--V--V--T- 
 
 
Figure 5b: Lamprey Opioid Receptor 1B 
               
     1 GTACACCAAGATGAAGACCGCTACCAACATCTACATCTTCAACCTGGCGCTGGCAGACGC 
     1 -Y--T--K--M--K--T--A--T--N--I--Y--I--F--N--L--A--L--A--D--A- 
        
    61 CCTCGCCACCAGCACCATGCCCTTCCAGAGCACCAACTACATGCTGGACACGTGGCCCTT 
    20 -L--A--T--S--T--M--P--F--Q--S--T--N--Y--M--L--D--T--W--P--F 
 
   121 CGGTCAGATCCTGTGCAAGCTCGTCATCTCCATCGACTACTACAACATGTTCACCAGCAT 
    40 --G--Q--I--L--C--K--L--V--I--S--I--D--Y--Y--N--M--F--T--S--I 
 
   181 CCTGACGCTCACCATGATGAGCGTGGACCGCTACATCGCCGTGTGCCACCCGGTCAGGGC 
    60 --L--T--L--T--M--M--S--V--D--R--Y--I--A--V--C--H--P--V--R--A 
 
   241 CCTGGACTTCCGCACGCCACGCAACGCCAAGCTCATCAACGTGTGCATCTGGCTGCTCTC 
    80 --L--D--F--R--T--P--R--N--A--K--L--I--N--V--C--I--W--L--L--S 
 
   301 CTCCACCGTGGGGCTGCCGGTCATCATCATGGCGGGCACGCAGTACAACAAGAAAG 
   100 --S--T--V--G--L--P--V--I--I--M--A--G--T--Q--Y--N--K--K- 
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Figure 5c: Lamprey Opioid Receptor 2A            
  
     
     1 ATGAAGACGGCCACAAACATCTACATTTTTAACCTGGCGCTGGCCGACGCTCTGGCGACG 
     1 -M--K--T--A--T--N--I--Y--I--F--N--L--A--L--A--D--A--L--A--T- 
       
    61 AGCACGCTGCCGTTCCAGAGCGCCGACTACATGCTGGGCACGTGGCCATTCGGGCCCATC 
    21 -S--T--L--P--F--Q--S--A--D--Y--M--L--G--T--W--P--F--G--P--I- 
 
   121 CTCTGCAAGGTGGTGATGTCCATCGACTACTACAACATGTTCACAAGCATCTTCACGCTC 
    41 -L--C--K--V--V--M--S--I--D--Y--Y--N--M--F--T--S--I--F--T--L- 
 
   181 ACCATGATGAGCGTCGACCGCTACGTCGCCGTGTGCCACCCGGTCAAGGCCCTCGACTTC 
    61 -T--M--M--S--V--D--R--Y--V--A--V--C--H--P--V--K--A--L--D--F- 
 
   241 CGCACGCCCACCAAGGCCAAGTTGATCAACGTCGCCATCTGGCTGCTCTCGTCTATCATC 
    81 -R--T--P--T--K--A--K--L--I--N--V--A--I--W--L--L--S--S--I--I- 
                                                       
   301 GGCGTCCCCATCATGATTATGGGCACCATCAAGCCTGACCAAATTG 
   101 -G--V--P--I--M--I--M--G--T--I--K--P--D--Q--I- 
 
 
Figure 5d: Lamprey Opioid Receptor 2B     
 
     1 ATGAAGACGGCTACCAACACGTACATCTTCAACCTTGCCCTGGCAGACACATTGGTCACC 
     1 -M--K--T--A--T--N--T--Y--I--F--N--L--A--L--A--D--T--L--V--T- 
         
    61 ACCACCTTGCCCTTCCAGAGTGCCGATTACCTCATGGGCTCGTGGCCTTTCGGAGAGGTG 
    21 -T--T--L--P--F--Q--S--A--D--Y--L--M--G--S--W--P--F--G--E--V- 
 
 
   121 ATCTGCAAGGTGGTGATGTCCATCGACTACTACAACATGTTCACCAGCATTTTCACGCTC 
    41 -I--C--K--V--V--M--S--I--D--Y--Y--N--M--F--T--S--I--F--T--L- 
 
   181 ACGATCATGAGCGTCGATCGCTACATCGCTGTGTGCCACCCGGTGAAGGCTCTGGACTTT 
    61 -T--I--M--S--V--D--R--Y--I--A--V--C--H--P--V--K--A--L--D--F- 
 
 
   241 CGGACACCCTCCAAGGCCAAGTTGATCAACATCTGCATCTGGATCCTGTCGTCAGCCATT 
    81 -R--T--P--S--K--A--K--L--I--N--I--C--I--W--I--L--S--S--A--I- 
 
   301 GGCATTCCCGTCATCGTCATGGGCACGGCCAAGAAAGAGGAGG 




Figure 5 a-d: Putative lamprey opioid receptors sequences at the nucleotide and amino 
acid levels. The gray highlighted sequence represents where each primer was ta geted 
and the arrows represent which direction the primers were designed to work. The lampr y 
sequences for 1A, 1B, 2A, and 2B can be found in the Ensembl Lamprey Genome under 





5. Gel Electrophoresis 
 The PCR products were analyzed using a 1% agarose gel made by combining 1g 
of agarose (ISC BioExpress, Kaysville, UT) with 100mL of 1X TAE buffer. The 1X TAE 
buffer was composed of 4.48g Tris, 1.142mL Acetic Acid, 0.5M EDTA (ph 8), and 1L 
dH2O. 10µl of 1mg/mL ethidium bromide (Sigma-Aldrich, St. Louis, MO) was added to 
the 1% agarose gel mixture. The PCR products were loaded into the gel with a 6X 
loading dye (Promega, Madison, WI) and a low range 100bp ladder (Fisher Scientific, 
Pittsburg, PA). The gel ran at 100-110V for 20-30 minutes and was then placed into a 
molecular imaging gel doc (Biorad, Hercules, CA) for visualization. The RT-PCR 
yielded a 600bp target band that was excised using Wizard SV Gel and PCR Clean-Up 
System (Promega, Madison, WI). 
 
6. Ligation and Transformation 
 The cleaned PCR product was ligated into the pGEM-T vector (Figure 6) at a 3:1 
insert:vector ratio according to pGEM-T and pGEM-T Easy Vector Systems (Promega, 
Madison, WI). The vector was then inserted into Z-competent E.coli DH5α cells (Zymo 
Research,Orange, CA) for transformation following the manufacturer’s 
recommendations. The bacteria containing the vector were grown on LB-Agar-
Ampicillin plates overnight. The LB-Agar-Amp plates were created by combining 10 g 
Tryptone, 5g yeast extract, 5g NaCl, 12g agar, and 1L dH2O. The transformants were 
selected by blue-white color screening. The white colonies were screened for the correct 
size insert using rapid cycle PCR (Wittwer et al, 1994). A small portion of the colony was 
picked off with a sterile pipette tip and dissolved in 10µl of water. 1µl of the dissolved 
28 
bacterial colony was used in a rapid cycle PCR as the DNA template. Gene specific 
primers, OpR-FWD and JM Degen REV, were used to ensure that the correct product 
was present within the vector. The PCR reagents included 1µl of each primer at 10µM, 
1µl of 10mM dNTP mix, 2µl of 10X Mg2+ buffer ( 500mM Tris pH 8.3, 2.5mg/mL BSA, 
and 30mM MgCl2), 0.1µl of Taq polymerase (Invitrogen, Carlsbad, CA) and 3.9µl of 
dH2O. The thermal profile consisted of  an initial denaturing step at 94ºC for two minutes 
followed by an additional 32 cycles, each cycle consisted of an annealing step at 47ºC  
for 15 seconds and an extension step at 72ºC. The rapid cycle PCR products were then 
electrophoresed on an agarose gel as described above. 
 
7. Colony Touch 
 A colony touch protocol developed by Hofmann and Brian 1991 was used to 
identify the plasmid DNA. The colonies containing the correct insert, according to the
rapid cycle PCR, were picked off using a sterile pipette tip and dissolved in 100µL of 
T.E.(10mM Tris, 0.1mM EDTA, pH 8). They were heated for 10 minutes at 100ºC and 
2µl was used as the DNA template in a 25µl PCR reaction. The PCR reagents wer a
follows: 2µl of each vector primer (SP6 and T7) at 10µM each, 2µl of 10mM dNTP mix, 
2µl of 10X PCR buffer (100mM Tris pH9.2, 750mM KCl, and 35mM MgCl2), 14.8µl of 
dH2O, 1U of Taq polymerase at 5U/µl (Invitrogen, Carlsbad, CA). The thermal profile 
allowed an initial pre-heat at 94ºC for three minutes followed by 32 cycles, each cycle 
consisting of a forty-five second denaturing step at 94ºC followed by an annealing step at 
55ºC for thirty seconds and an extension step at 72ºC for one minute and a half. A final 
step at 72ºC for ten minutes concluded the thermal profile. 5µl of the PCR product was 
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electrophoresed on an agarose gel as described above. The products containing the 
correct sized insert (size of the cloned insert plus the size of the multiple cloning region 
within the vector) were prepared for sequencing as follows: 5U of Exonuclease I (5U/µl, 
USB, Cleveland, OH) and 0.5U of shrimp alkaline phosphatase (1U/µl, USB, Cleveland, 
OH) was added to the remaining 20µl PCR product and a 37ºC incubation followed. The 



































Figure 6: pGEM-T vector circle map and sequence reference points (Promega, Madison, 
WY). The gray highlighted section shows the T7 RNA polymerase transcription 










 The purified PCR products were labeled for sequencing using the CEQ-DTCS 
Quickstart Kit (Beckman-Coulter, Fullerton, CA) following the manufacturer’s 
recommendations and sequenced on the CEQ 8000 XL DNA Analysis System 
(Beckman-Coulter, Fullerton, CA). The sequence data chromatograms were analyzed 
using Sequencher 4.9 (Gene Codes, Ann Arbor, MI). The sequences were submitted to 
NCBI’s BLAST search engine and compared to known sequences. 
 
9. Primer Design 
White Sturgeon and Horn Shark 
 All four zebrafish opioid receptors were aligned at the amino acid level using the 
multiple alignment program Clustal W2. Opioid/orphanin sequences from human, 
chicken, xenopus tropicalus, and zebrafish were also aligned at the amino acid level for 
each individual receptor using ClustalW2. Based on these alignments, highly conserved 
regions within the opioid/orphanin receptors were chosen as targets for primer design 
(Figure 4). Each primer designed was then analyzed for hairpin loops, 3’ 
complementarities, and self-annealing sites using the Oligonucleotide Prop rties 
Calculator(Northwestern University Medical School, Chicago, IL). 
Lamprey 
 The Ensembl Genome Browser was utilized to probe the Lamprey genome for 
possible opioid/orphanin receptor sequences. Using the sea lamprey genus and species, 
Petromyzon marinus, known opioid/orphanin receptor sequences from zebrafish were use 
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to screen the entire lamprey genome at the amino acid level using the BLASTN option. 
Once the results were retrieved, the “graphical view” revealed the alignment and location 
of the closest match. Both the nucleotide and amino acid sequences were displayed and 
through a process of elimination, based on conserved transmembrane domains within 
opioid/orphanin sequences, four lamprey receptors sequences assigned the names 1A, 1B, 
2A, and 2B were retrieved. Using those nucleotide sequences forward and reverse 
primers were designed for each of the four different lamprey receptor sequences (see Fig 
5 a-d). The primer design was analyzed using Oligonucleotide Properties Calculator as 
above.  
 
10. Phylogenetic Analyses 
Alignments performed by ClustalW were refined manually following the 
procedures outlined in Dores t al (1996). Phylogenetic analyses were aligned and 
analyzed using the exhaustive search mode of the maximum parsimony algorithm (PAUP 
4.1). Lamprey prosomatostatin (Lamprey Genome Project; Contig 25590.1 314-1366) 








 The first round of RT-PCR yielded a fragment from lamprey, horn shark and 
white sturgeon that were approximately 600 base pairs (bp) in length. The fragment was 
amplified using the degenerate forward primer (OpR-Fwd) designed by Li et al. in (1996) 
and the JMDR reverse primer. OpR-Fwd was targeted to the sequence KTATNIY, found 
just outside and within the second transmembrane spanning region (TM2) and JMDR was 
targeted to the sequence CWTPI(H,Q)I, found within the sixth transmembrane spanning 
region(TM6).  
Using the Primer Design procedure for Lamprey outlined in the Materials and 
Methods section, four separate lamprey receptor fragments were also obtained. The 
lamprey receptor 1A yielded a 573bp fragment, 1B yielded a 266bp fragment, 2A yielded 
a 291bp fragment, and 2B yielded a 333bp fragment.  
After the fragments were isolated a total of ten bacterial colonies from white 
sturgeon, ten bacterial colonies from horn shark and thirty bacterial colonies from 
lamprey were screened, sequenced, and submitted the National Center for Biotechnolgy 
Information (NCBI) database using the blastn (nucleotide blast) option as described in 
Materials and Methods. 
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The clones were compared to a collection of sequences submitted to the NCBI 
database for identification The white sturgeon clones revealed five kappa-like sequences 
and five ORL-like sequences. Of the ten horn shark clones, all were identified as delta-
like sequences. The lamprey clones revealed fifteen delta-like sequences, t delta 
variants, and five mu-like sequences.  
 The raw sequence data were then used to create a consensus sequence for each 
receptor. The chromatograms for each sequence in every receptor were aligned nd 
analyzed in Sequencher. Each base corresponded to a certain peak in the chromatograms; 
therefore, every base that differed from the others was either changed or deleted 
according to the strength of the peaks that corresponded to the most frequently occurring 
base at that point in the sequence. Through this process a consensus sequence for each 
receptor in every organism emerged. 
 
B. Lamprey Receptors 
 The fragment (lamprey DG) obtained from lamprey using the degenerate fo ward 
primer OPR-Fwd and the degenerate reverse primer JMDR (for reference se prim r 
design in Materials and Methods section) spans from the second transmembrane domain 
to the sixth transmembrane domain. The deduced amino acid sequence is 204 residues in 
length and includes the end of the first intracellular loop, the entire second and third 
intracellular loops, and the entire first and second extracellular loops (Figure 7). The 
cloned lamprey fragment 2A is a smaller portion of this cloned fragment and from here 
forward will be referred to with the lamprey DG. 
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                                TM II 
 K  T  A  T  N  I  Y  I  F  N  L  A  L  A  D  A    16 
AAGACGGCGACGAACATCTACATTTTTAACCTGGCGCTGGCCGACGCT   48 
 
 L  A  T  S  T  L  P  F  Q  S  A  D  Y  M  L  G    32 
CTGGCGACGAGCACGCTGCCGTTCCAGAGCGCCGACTACATGCTGGGC   96 
 
 T  W  P  F  G  P  I  L  C  K  V  V  M  S  I  D    48 
ACGTGGCCATTCGGGCCCATCCTCTGCAAGGTGGTGATGTCCATCGAC  144 
                     TM III 
 Y  Y  N  M  F  T  S  I  F  T  L  T  M  M  S  V    64 
TACTACAACATGTTCACAAGCATCTTCACGCTCACCATGATGAGCGTC  192 
 
 D  R  Y  V  A  V  C  H  P  V  K  A  L  D  F  R    80 
GACCGCTACGTCGCCGTGTGCCACCCGGTCAAGGCCCTCGACTTCCGC  240 
                                 TM IV 
 T  P  T  K  A  K  L  I  N  V  A  I  W  L  L  S    96 
ACGCCCACCAAGGCCAAGTTGATCAACGTCGCCATCTGGCTGCTCTCG  288 
 
 S  I  I  G  V  P  I  M  I  M  G  T  I  K  P  D   112 
TCTATCATCGGCGTCCCCATCATGATTATGGGCACCATCAAGCCTGAC  336 
 
 Q  I  G  Y  M  E  C  L  V  V  F  P  Q  P  P  W   128 
CAAATTGGCTACATGGAGTGCCTGGTGGTCTTCCCGCAGCCGCCCTGG  384 
 
 F  W  E  T  L  L  K  I  C  V  F  I  F  A  F  I   144 
TTCTGGGAAACCCTGCTGAAGATCTGCGTGTTCATCTTCGCCTTCATC  432 
                        TM V 
 M  P  V  M  I  I  T  I  C  Y  G  L  M  I  L  R   160 
ATGCCCGTCATGATCATCACCATCTGCTACGGCCTCATGATTCTGCGC  480 
 
 L  R  T  V  R  L  F  S  G  S  K  E  K  D  R  N   176 
TTGCGCACCGTGCGCCTCTTCTCGGGCTCCAAGGAGAAGGACCGCAAC  528 
                                 TM VI 
 L  R  R  I  T  R  M  V  L  V  V  V  A  V  F  I   192 
CTCCGACGCATCACGCGCATGGTCCTGGTGGTGGTGGCGGTCTTCATC  576 
 
 V  C  W  T  P  I  H  I  N  R  I  P               204 




Figure 7 Lamprey DG: Deduced amino acid and nucleotide sequence of  the  putative 
lamprey DOR fragment from the RT-PCR using the forward degenerate primer designed 
by Li et al. (1996) and the reverse primer JM Degen Rev. Transmembrane domains are 
highlighted in gray with the TM number above and the sequence to which the primers 
were targeted are underlined 
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 The lamprey 1A fragment obtained using homologous primers targeted to the first 
intracellular loop and the sixth transmembrane region (for reference see primer design in 
Materials and Methods section) has a deduced amino acid sequence of 191 residues, 
which includes the end of the first intracellular loop, the entire second and third 
intracellular loops, and the entire first and second extracellular loops (Figure 8). 
 The fragment for lamprey 1B was retrieved using homologous primers targeted to 
the second transmembrane domain and the fourth transmembrane domain (for reference 
see primer design in Materials and Methods section). It has a deduced amino acid 
sequence of 88 residues which includes transmembrane domains 1-4, the end of the first 
intracellular loop, the entire second intracellular loop, and the entire first ext ac llular 
loop (Figure 9). 
 The lamprey 2A fragment was obtained using a degenerate forward primer
targeted to the end of the first intracellular loop and the beginning of the second 
transmembrane domain and a homologous reverse primer targeted to the fourth 
transmembrane domain (for reference see primer design in Materials and Methods 
section). The deduced amino acid sequence is ninety-seven residues in length turned out 
to be an identical smaller portion of the lamprey DG fragment. It represents amino cid 
residues 2-97 of lamprey DG (Figure 7) and from this point forward will be combined 







                                                                      TM II 
 K  T  A  T  N  I  Y  I  F  N  L  A  L  A  D  T    16 
AAAACCGCCACCAACATTTATATCTTCAACCTGGCTCTGGCCGACACG   48 
 
 L  A  T  S  T  L  P  F  Q  I  V  N  Y  F  M  S    32 
CTGGCCACCAGCACCCTGCCCTTCCAGATTGTCAACTACTTCATGAGC   96 
 
 T  W  P  F  G  R  V  L  C  K  L  I  I  S  I  D    48 
ACATGGCCCTTCGGTCGCGTCCTCTGCAAGCTCATCATCTCCATAGAC  144 
                    TM III 
 Y  Y  N  M  F  T  S  I  F  T  L  T  M  M  S  I    64 
TATTATAACATGTTCACGAGCATCTTCACGCTCACCATGATGAGCATC  192 
 
 D  R  Y  I  A  V  C  H  P  V  R  A  L  D  F  R    80 
GACCGATACATCGCCGTGTGCCACCCGGTGAGGGCGCTGGATTTCCGA  240 
                              TM IV 
 T  P  V  K  A  K  L  V  N  I  C  I  W  S  L  S    96 
ACGCCCGTCAAGGCCAAGCTCGTTAATATCTGCATCTGGTCGCTGTCA  288 
 
 S  A  I  G  L  P  V  M  I  I  A  V  T  K  Q  D   112 
TCTGCCATCGGCCTGCCCGTCATGATCATTGCGGTGACCAAGCAGGAT  336 
 
 K  N  G  N  V  D  C  T  L  E  F  P  I  Y  W  D   128 
AAGAACGGCAACGTGGACTGCACGCTGGAGTTCCCCATCTACTGGGAC  384 
                                 TM V 
 N  M  L  K  T  C  V  F  V  F  A  F  F  I  P  V   144 
AACATGCTGAAGACGTGCGTGTTCGTGTTCGCCTTCTTCATCCCCGTG  432 
 
 C  V  I  T  V  C  Y  G  L  M  I  T  R  L  R  S   160 
TGTGTCATCACCGTCTGCTATGGCCTCATGATCACGCGCCTGCGCAGC  480 
 
 V  R  V  L  S  G  S  K  E  K  D  R  T  M  R  R   176 
GTGCGCGTGCTCTCGGGCTCCAAGGAGAAGGACCGCACCATGCGGCGC  528 
                        TM VI 
 I  T  R  M  V  L  V  V  G  P  P  S  W  C  A      191   




Figure 8 Lamprey 1A: Deduced amino acid and nucleotide sequence of the putative 
lamprey DOR fragment from the RT-PCR using a homologous forward and reverse 
designed as mentioned above in the Materials and Methods section. Transmembrane 
domains are highlighted in gray with the TM number above and the sequence that the 





                         
 
 
                           TM II 
 T  A  T  N  I  Y  I  F  N  L  A  L  A  D  A  L    16 
ACCGCTACCAACATCTACATCTTCAACCTGGCGCTGGCAGACGCCCTC   48 
 
 A  T  S  T  M  P  F  Q  S  T  N  Y  M  L  D  T    32 
GCCACCAGCACCATGCCCTTCCAGAGCACCAACTACATGCTGGACACG   96 
 
 W  P  F  G  Q  I  L  C  K  L  V  I  S  I  D  Y    48 
TGGCCCTTCGGTCAGATCCTGTGCAAGCTCGTCATCTCCATCGACTAC  144 
                     TM III 
 Y  N  M  F  T  S  I  L  T  L  T  M  M  S  V  D    64 
TACAACATGTTCACCAGCATCCTGACGCTCACCATGATGAGCGTGGAC  192 
 
 R  Y  I  A  V  C  H  P  V  R  A  L  D  F  R  T    80 
CGCTACATCGCCGTGTGCCACCCGGTCAGGGCCCTGGACTTCCGCACG  240 
                 TM IV 
 P  R  N  A  K  L  I  N                            88 









Figure 9 Lamprey 1B: Deduced amino acid and nucleotide sequence of the putative 
lamprey MOR fragment from the RT-PCR using a homologous forward and reverse 
designed as mentioned above in the Materials and Methods section. Transmembrane 
domains are highlighted in gray with the TM number above and the sequence that the 







 Finally, the lamprey 2B fragment was retrieved using a homologous forward 
primer targeted between the end of the first intracellular loop and the second 
transmembrane region and a homologous reverse primer targeted to the end of the fourth 
transmembrane region (for reference see primer design in Materials and Methods 
section). It has a deduced amino acid sequence of 111 residues that includes 
transmembrane domains 1-4, part of the first intracellular loop, the entire second 
intracellular loop, the entire first extracellular loop, and the beginning of the second 



















                                    
                                                                 TM II 
 K  T  A  T  N  T  Y  I  F  N  L  A  L  A  D  T    16 
AAGACGGCTACCAACACGTACATCTTCAACCTTGCCCTGGCAGACACA   48 
 
 L  V  T  T  T  L  P  F  Q  S  A  D  Y  L  M  G    32 
TTGGTCACCACCACCTTGCCCTTCCAGAGTGCCGATTACCTCATGGGC   96 
 
 S  W  P  F  G  E  V  I  C  K  V  V  M  S  I  D    48 
TCGTGGCCTTTCGGAGAGGTGATCTGCAAGGTGGTGATGTCCATCGAC  144 
                     TM III 
 Y  Y  N  M  F  T  S  I  F  T  L  T  I  M  S  V    64 
TACTACAACATGTTCACCAGTATTTTCACGCTCACGATCATGAGCGTC  192 
 
 D  R  Y  I  A  V  C  H  P  V  K  A  L  D  F  R    80 
GATCGCTACATCGCTGTGTGCCACCCGGTGAAGGCTCTGGACTTTCGG  240 
                              TM IV 
 T  P  S  K  A  K  L  I  N  I  C  I  W  I  L  S    96 
ACACCCTCCAAGGCCAAGTTGATCAACATCTGCATCTGGATCCTGTCG  288 
 
 S  A  I  G  I  P  V  I  V  M  G  T  A  K  K      111 







Figure 10 Lamprey 2B: Deduced amino acid and nucleotide sequence of the putative 
lamprey DOR variant fragment from the RT-PCR using a homologous forward and 
reverse designed as mentioned above in the Materials and Methods section. 
Transmembrane domains are highlighted in gray with the TM number above and the 










C. Horn Shark Receptors 
The horn shark fragment obtained using the degenerate OPR-Fwd primer and 
JMDR reverse primer (for reference see primer design in Materials and Methods section) 
spans from the second transmembrane domain to the sixth transmembrane domain. The 
deduced amino acid sequence is 200 residues in length and includes the end of the first 
intracellular loop, the entire second and third intracellular loops, and the entire firs  and 
second extracellular loops (Figure 11). 
 
D. White Sturgeon Receptors 
 The fragments obtained from the white sturgeon using the degenerate OPR-Fwd 
primer and degenerate JMDR reverse primer span from the second transmembrane 
domain to the sixth transmembrane domain with a deduced amino acid sequence of 199  
residues for the kappa-like sequences and 201 residues for the ORL-like sequences. The 
fragments contain part of the first intracellular loop, the entire second and third 
intracellular loops, and the entire first and second extracellular loops. The ORL-like 
fragment is shown in Figure 12 and the kappa-like receptor is shown in Figure 13. 
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                                                                       TM II 
 K  T  A  T  N  I  Y  I  F  N  L  A  L  A  D  A    16  
AAGACGGCGACGAACATTTATATCTTCAACCTTGCCCTGGCAGACGCA   48   
 
 L  A  T  S  S  L  P  F  Q  S  A  K  Y  L  M  D    32  
CTCGCCACGAGCTCACTGCCATTTCAGAGTGCCAAATATTTGATGGAT   96  
                
 T  W  P  F  G  E  L  L  C  K  T  V  L  S  I  D    48 
ACGTGGCCCTTCGGGGAGCTCTTGTGCAAAACAGTCCTATCAATTGAC  144 
                        TM III 
 Y  Y  N  M  F  T  S  I  F  T  L  T  M  M  S  V    64 
TACTACAATATGTTCACCAGCATCTTCACCCTCACCATGATGAGTGTC  192  
 
 D  R  Y  I  A  V  C  H  P  V  K  A  L  D  F  R    80 
GATCGTTACATTGCCGTCTGCCACCCTGTTAAGGCGTTAGATTTCCGC  240 
                              TM IV 
 T  P  M  N  A  K  I  V  N  V  C  V  W  L  L  S    96 
ACACCCATGAACGCAAAGATCGTCAACGTCTGCGTGTGGCTACTGTCA  288 
 
 S  A  I  G  V  P  V  M  V  M  A  V  T  K  P  N   112 
TCTGCCATAGGAGTCCCAGTCATGGTCATGGCTGTCACCAAACCCAAC  336 
 
 S  K  G  N  V  M  C  T  I  Q  F  P  A  P  T  W   128 
AGTAAAGGTAACGTGATGTGTACCATACAATTTCCAGCGCCCACTTGG  384 
                                 TM V 
 Y  W  D  N  V  T  K  I  C  V  F  I  F  A  F  V   144 
TACTGGGATAATGTAACCAAAATCTGTGTCTTCATATTTGCCTTTGTG  432 
 
 I  P  V  L  V  I  T  I  C  Y  G  L  M  I  L  R   160 
ATACCAGTCCTGGTCATAACCATCTGCTACGGCCTGATGATTCTGCGC  480 
 
 L  K  S  V  R  L  L  S  G  S  K  E  K  D  R  N   176 
CTGAAAAGCGTCCGACTCCTTTCAGGCTCCAAAGAGAAGGACAGAAAC  528 
                                TM VI 
 L  R  R  I  T  R  M  V  L  V  V  V  A  I  F  I   192 
CTGCGGAGGATCACACGAATGGTCCTAGTGGTGGTGGCCATCTTTATC  576 
 
 I  C  W  T  P  I  Q  I                           200  
ATCTGCTGGACACCCATCCAAATA                          600 
 
Figure 11 HS DOR: Deduced amino acid and nucleotide sequence of  the  putative horn 
shark DOR fragment from the RT-PCR using the forward degenerate primer designed by 
Li et al. (1996) and the reverse primer JM Degen Rev. Transmembrane domains are 
highlighted in gray with the TM number above and the sequence that the primers were 




      TM II 
 K  T  A  T  N  I  Y  I  F  N  L  A  L  A  D  F    16 
AAGACGGCGACGAATATATACATCTTTAACCTGGCCCTTGCAGACTTT   48 
 
 L  V  L  L  T  L  P  F  Q  G  T  D  V  F  L  G    32   
CTGGTTCTCCTCACCTTACCTTTCCAAGGCACAGACGTTTTCCTTGGG   96 
 
 S  W  P  F  G  K  L  L  C  K  I  V  I  A  I  D    48 
TCCTGGCCGTTTGGTAAACTCCTCTGCAAGATAGTGATCGCAATCGAT  144 
                TM III  
 Y  Y  N  M  F  T  S  T  F  T  L  T  M  M  S  V    64 
TATTATAACATGTTCACCAGCACCTTCACCCTCACCATGATGAGCGTG  192 
 
 D  R  Y  I  A  V  C  H  P  V  K  A  L  D  M  R    80 
GATCGGTACATCGCCGTCTGCCATCCAGTGAAAGCCCTGGACATGCGA  240 
                                    TM IV 
 T  P  H  K  A  K  V  V  N  I  C  I  W  A  L  A    96 
ACCCCTCACAAAGCTAAAGTCGTCAACATCTGCATCTGGGCTTTGGCT  288 
 
 S  V  I  G  I  P  A  M  V  M  G  D  V  E  E  D   112   
TCTGTAATCGGTATACCAGCCATGGTGATGGGGGATGTTGAAGAGGAT  336 
 
 P  Y  G  T  A  I  E  C  A  V  V  L  P  Q  P  C   128   
CCCTATGGCACAGCTATCGAGTGCGCTGTGGTCCTGCCTCAGCCCTGC  384 
 
 S  F  C  D  A  V  F  G  T  C  V  F  I  F  S  F   144   
AGCTTCTGCGACGCTGTATTTGGCACCTGTGTATTCATCTTCTCCTTC  432 
                    TM V 
 V  V  P  V  A  I  I  T  I  C  Y  T  L  M  V  K   160 
GTCGTCCCGGTCGCCATTATCACCATCTGCTACACCCTGATGGTGAAG  480 
 
 R  L  K  N  V  R  V  L  S  G  S  K  E  K  D  R   176 
CGCTTGAAAAACGTGCGGGTGCTGTCCGGCTCCAAGGAGAAGGACCGC  528 
 
 M  L  R  R  I  T  R  M  V  L  I  V  V  A  V  F   192  
ATGCTGCGCCGCATCACGCGGATGGTCCTCATCGTGGTGGCGGTCTTC  576 
 
 V  V  C  W  T  P  I  Q  I                        201 
GTTGTCTGCTGGACCCCAATACAAATA                       603 
 
Figure 12 WS ORL: Deduced amino acid and nucleotide sequence of  the  putative 
white sturgeon ORL fragment from the RT-PCR using the forward degenerate primer
designed by Li et al. (1996) and the reverse primer JMDR. Transmembrane domains are 
highlighted in gray with the TM number above and the sequence that the primers were 




             TM II 
 K  T  A  T  N  I  Y  I  F  N  L  A  V  A  D  A    16 
AAGACGGCGACGAACATCTACATTTTTAATCTAGCTGTGGCTGATGCT   48     
  
 F  V  T  T  T  M  P  F  Q  S  T  D  Y  L  L  G    32 
TTTGTTACCACGACAATGCCCTTTCAGAGTACGGACTACTTGTTAGGT   96  
 
 T  W  P  F  G  E  V  V  C  K  I  F  I  S  I  D    48   
ACATGGCCTTTTGGGGAAGTAGTCTGCAAAATATTTATTTCAATAGAT  144 
                         TM III 
 Y  Y  N  M  F  T  S  I  F  T  L  T  M  M  S  V    64 
TACTATAACATGTTCACCAGCATCTTCACATTGACCATGATGAGTGTT  192 
 
 D  R  Y  I  A  V  C  H  P  V  K  A  L  D  F  R    80 
GACCGGTACATTGCTGTTTGCCACCCTGTAAAGGCCCTTGATTTTCGC  240  
 
 T  P  V  K  A  K  I  I  N  V  C  I  W  I  L  S    96 
ACACCGGTAAAGGCCAAGATAATTAACGTTTGTATCTGGATACTCTCA  288 
                 TM IV 
 S  A  A  G  I  P  A  L  I  L  G  S  T  E  T  N   112 
TCAGCAGCTGGTATACCTGCACTGATCCTGGGAAGCACAGAAACTAAT   36 
 
 H  G  T  T  E  C  A  L  Q  F  P  E  P  Y  V  Y   128 
CATGGTACCACAGAATGTGCTTTGCAGTTCCCAGAACCGTATGTGTAC  384 
                                 TM V 
 W  D  T  L  M  K  I  C  V  F  I  F  A  F  V  V   144 
TGGGACACCCTCATGAAAATCTGTGTTTTCATTTTTGCATTCGTTGTG  432 
 
 P  V  L  I  I  T  V  C  Y  T  L  M  I  L  R  L   160 
CCAGTTCTCATCATTACAGTGTGCTACACCTTAATGATCCTGCGCCTG  480 
 
 K  S  V  R  L  L  S  G  S  R  E  K  D  R  N  L   176 
AAAAGTGTCCGACTCCTGTCTGGCTCCAGGGAGAAGGACCGAAACTTG  528 
                                TM VI 
 R  R  I  T  K  L  V  L  V  V  V  A  V  F  I  I   192 
CGTCGCATCACAAAGCTCGTGTTAGTGGTGGTGGCTGTTTTCATCATC  576 
 
 C  W  T  P  I  H  I                              199 
TGCTGGACCCCTATCCACATC                             597 
 
Figure 13 WS KOR: Deduced amino acid and nucleotide sequence of  the putative white 
sturgeon Kappa-like fragment from the RT-PCR using the forward degenerate primer 
designed by Li et al. (1996) and the reverse primer JM Degen Rev. Transmembrane 
domains are highlighted in gray with the TM number above and the sequence that the 
primers were targeted to are underlined. 
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E. Vertebrate Amino Acid Alignments 
 Each partial receptor sequence was aligned with other known vertebrate 
sequences to provide further support to the BLAST results. A representative from each 
vertebrate group was used to provide a complete picture of the opioid/orphanin receptor 
vertebrate evolution. Humans were used for the mammalian group, chicken was used for 
the avian species, either rough-skinned newt (Taricha granulose) or Xenopus tropicalis 
was used for the amphibian group, and zebrafish was used for the fish group. The animals 
cloned in this study extend the fish species to include the oldest members of the 
vertebrate class, with lamprey representing jawless fish, horn shark representing 
cartilaginous fish, and white sturgeon representing ray-finned fish. Comparing the amino 
acid sequence identities over a broad taxonomic range further establishes the placement 
and evolutionary relationship of each receptor clone. It provides another visual 
understanding of how closely opioid/orphanin receptors are related.  
The lamprey fragments all showed a close relationship according to the 
preliminary BLAST results, therefore all of the lamprey clones were aligned together 
with other vertebrate DOR’s (Figure 18). However, because the LR DG fragment, based 
on the primary sequence, was shown to be more delta-like with the BLAST search and 
more mu-like  with the phylogenetic analysis, it was aligned with both DORand MOR 
vertebrates to reveal which receptor it shared the most sequence identity. The LR DG 
receptor shows the highest sequence identity with DOR’s in the intracellular loops with 
ranges from 90% in newt and zebrafish to 94% in chicken. The zebrafish DOR shows the 
lowest sequence identity with the LR DG fragment at only 72%. The ZDOR 
transmembrane regions, which are normally highly conserved among opioid recepto s, 
share only 71% sequence identity with the LR DG fragment (Table 3). When aligned 
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with vertebrate MOR’s (Figure 19), the LR DG fragment shares 83% sequence identity 
with the ZMOR within the transmembrane domains and an overall sequence identity of 
76% (Table 3). Among the different vertebrates included in the alignments, zebrafish 
should show the highest sequence identity with the LR DG fragment because they both 
belong to the vertebrate class of fish. Taking this into consideration, along with the 
phylogenetic analysis, it seems likely that the LR DG fragment is more closely related to 
MOR. 
The lamprey 1A fragment shows the highest sequence identities within the 
transmembrane domains and the intracellular loops (Figure 18). Sequence identities 
within the intracellular loops ranged from 86% in chicken to 92% in newt and zebrafish. 
The newt and zebrafish also showed the highest amino acid identity within the 
transmembrane domains at 72%. Interestingly, the extracellular loops seem to increase in 
sequence identity as the vertebrates evolve with the lowest sequence identity pr sent in 
zebrafish at only 49%.  In general, the LR 1A fragment shows 71%-73% overall 
sequence identity with vertebrate DOR’s (Table 4). 
The lamprey 1B and 2B fragments both show very high sequence identity with 
vertebrate DOR’s due in part to the small portion of amino acid residues involved in the 
alignment (Figure 18). LR 1B and 2B were only 88 amino acids and 111 amino acid 
residues in length, respectively. Both fragments show the highest sequence identities 
within the transmembrane domains and intracellular loops with identities ranging from 
85-96%. Even within the extracellular loops, LR 1B shows 61% sequence identity and 
LR 2B shows 67% sequence identity. Both fragments show an overall 82-85% sequence 




Human - M E P A P S A G A E L Q P P L F A N A S D A Y P S A C P S - - - - A G A N A S G P P G A R S A S S L - 
Chicken - M E L N T E L P T - - E P P A A W D N - R T A W D A L P G - - - - A G G N E T G P P R A K N A T S I - 
Newt - M E L S T M S G A G L Y P D F L F Y N - A T S F N - F N G - - - - S - L N E T R P F P V K N I T S I - 
Z.Fish - M E P P T V T V S D F S E R Y P L F L H N S S F L E E P A D F C P T G A E E A V A E G G E R Q Q C G - 
- 
I                                                     
Human - A L A I A I T A L Y S A V C A V G L L G N V L V M F G I V R Y T K M K T A T N I Y I F N L A L A D A - 
LR 1B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - T A T N I Y I F N L A L A D A - 
LR 1A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - K T A T N I Y I F N L A L A D T - 
Chicken - L I A I V I T A L Y S V V C V V G L L G N V L V M Y G I V R Y T K M K T A T N I Y I F N L A L A D A - 
Newt - V I A I A I T A L Y S V V C V V G L L G N I L V M Y G I V R Y T K M K T A T N I Y I F N L A L A D A - 
LR DG - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - K T A T N I Y I F N L A L A D A - 
LR 2B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - T A T N M Y I F N L A L A D A - 
Z.Fish - V I A V S I T A L Y S V I C V V G L V G N V L V M Y G V V R Y T K M K T A T N I Y I F N L A L A D A - 




                                                    
Human - L A T S T L P F Q S A K Y L M E T W P F G E L L C K A V L S I D Y Y N M F T S I F T L T M M S V D R - 
LR 1B - L A T S T M P F Q S T N Y M L D T W P F G Q I L C K L V I S I D Y Y N M F T S I L T L T M M S V D R - 
LR 1A - L A T S T L P F Q I V N Y F M S T W P F G R V L C K L I I S I D Y Y N M F T S I F T L T M M S I D R - 
Chicken - L A T S T L P F Q S A K Y L M E T W P F G E L L C K L V L S I D Y Y N M F T S I F T L T M M S V D R - 
Newt - L A T S T L P F Q S A K Y L M E T W P F G E L L C K V V L S I D Y Y N M F T S I F T L T M M S V D R - 
LR DG - L A T S T L P F Q S A D Y M L G T W P F G P I L C K V V M S I D Y Y N M F T S I F T L T M M S V D R - 
LR 2B - L A T S T L P F Q S A D Y M L G T W P F G P I L C K V V M S I D Y Y N M F T S I F T L T M M S V D R - 
Z.Fish - L A T S T L P F Q S A K Y L M G T W P F G E L L C K V V I A I D Y Y N M F T S I F T L T M M S V D R - 




                                                    
Human - Y I A V C H P V K A L D F R T P A K A K L I N I C I W V L A S G V G V P I M V M A V T R P - R D G A - 
LR 1B - Y I A V C H P V R A L D F R T P R N A K L I N - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
LR 1A - Y I A V C H P V R A L D F R T P V K A K L V N I C I W S L S S A I G L P V M I I A V T K Q D K N G N - 
Chicken - Y V A V C H P V K A L D F R T P A K A K V I N V C I W V L S S V I G V P I M V M A V T K T - K D G T - 
Newt - Y V A V C H P V R A L D F R T P V K A K I I N V C I W I L S S I I G V P I M V M A V T K T D K A G T - 
LR DG - Y V A V C H P V K A L D F R T P T K A K L I N V A I W L L S S I I G V P I M I M G T I K P D Q I G Y - 
LR 2B - Y V A V C H P V K A L D F R T P T K A K L I N V A I W L L S S I - - - - - - - - - - - - - - - - - - - 
Z.Fish - Y I A V C H P V R A L D F R T P V K A K I I N I C V W I L S S A V G F P V M V M A V T K E L D S G K - 









                                                    









Human - V V C M L Q F P S P S W Y W D T V T K I C V F L F A F V V P I L I I T V C Y G L M L L R L R S V R L - 
LR 1A - V D C T L E F P - - - I Y W D N M L K T C V F V F A F F I P V C V I T V C Y G L M I T R L R S V R V - 
Chicken - V L C T L Q F P D P P I Y W D T V T K I C V F I F A F M V P I L V I T I C Y G L M I L R L K S V R L - 
Newt - T Y C T L Q F P G P E G Y W D T V T K I C V F I F A F L V P V L V I T I C Y G L M I L R L K S V R L - 
LR DG - M E C L V V F P Q P P W F W E T L L K I C V F I F A F I M P V M I I T I C Y G L M I L R L R T V R L - 
Z.Fish - T I C M L K F P D P E W Y W D T V T K I C V F I F A F V F P V L V I T V C Y G L M I L R L K S V R L - 
Horn shark - V M C T I Q F P A P T W Y W D N V T K I C V F I F A F V I P V L V I T I C Y G L M I L R L K S V R L - 
I 
                                                     
Human - L S G S K E K D R S L R R I T R M V L V V V G A F V V C W A P I H I F V I V W T L V D I D R R D P L - 
LR 1A - L S G S K E K D R T M R R I T R M V L V V G - - - P P S W C A - - - - - - - - - - - - - - - - - - - - 
Chicken - L S G S K E K D R N L R R I T R M V L V V V A A F I I C W T P I H I F V I V W T L V D I D K K N P Y - 
Newt - L S G S K E K D R N M R R I T R M V L V V V A A F I I C W T P I H I F V I V W T M V D I D K K N P F - 
LR DG - F S G S K E K D R N L R R I T R M V L V V V A V F I V C W T P I H I N R I P - - - - - - - - - - - - - 
Z.Fish - L S G S K E K D R N L R R I T R - C F S G G G A F I I C W T P I H I F I I V K T V V E I D Q K N L L - 
Horn shark - L S G S K E K D R N L R R I T R M V L V V V A I F I I C W T P I Q I - - - - - - - - - - - - - - - - - 
I                          
 
 
                          
Human - V V A A L H L C I A L G Y A N S S L N P V L Y A F L D E N F K R C F R Q L C R K P C G R P D P S S F - 
Chicken - V V A S L H F C I A L G Y T N S S L N P V L Y A F L D E N F K R C F R E F C L P F R A R V E Q N S F - 
Newt - V I A S W H F C I A L G Y T N S S L N P V L Y A F L D E N F K R C F R D F C L P F R A R M E Q S S F - 
Z.Fish - V V A C W H L C I A L G Y M N S S L N P V L Y A F L D E N F K R C F R E F C L P F R T R I E Q N S F - 
I 
                                                     
Human - S R A R E A T A R E R V T A C T P S D G P G G G A A A                        - 
Chicken -  S R A R N T T - R E R V S T C A P S D S R G Q P A - -                        - 
Newt -   T R A K N A T - R E R V S T C A P S D V M N K P V - -                        - 
Z.Fish -   S K A R - S V I R E P I S V C A K T E S I K Q P T - -                        - 






Figure 14 DOR vertebrate alignment: Each animal was aligned using ClustalW and 
only the conserved regions for all five groups are shaded in gray. (-) represent gaps 
inserted where no base is present. The vertebrate sequences for human, chicken, rough-
skinned newt, and zebrafish can be found in the NCBI database using the accession 
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 Human Chicken Newt Zebrafish 
ICL’s 92% 94% 90% 90% 
ECL’s 51% 51% 51% 53% 
TM’s 75% 82% 84% 71% 
Overall 78% 74% 78% 72% 
       
 
 
Table 3 LR DG Amino Acid % Identity:  This table shows the amino acid % identities 
of the intracellular loops (ICL), extracellular loops (ECL), and transmembrane domains 
(TM) for only the partial (204 residues) amino acid fragment cloned. Amino acid % 
identities are present for human, chicken, Xenopus tropicalis (X.trop), and zebrafish. 
Percent identities include the gaps inserted during the multiple sequence alignment 
performed by ClustalW. 
 
 








 Human Chicken Newt Zebrafish 
ICL’s 86% 88% 86% 86% 
ECL’s 53% 53% 51% 49% 
TM’s 83% 83% 83% 83% 
Overall 77% 77% 77% 76% 
50 
Human - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chicken - A G A L E V P F G A N A S A A A C R P A V P P C A A A P P G A W G N S T A G W N R S E P C G G A N G - 
X.Trop - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Z.fish - - - - - - - - - - - - M M E N T G N I S D L L Y A L S N P M V S N S S I L C R N F S N S S G L V N M - 




                                                   
Human - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chicken - - S A G G G P C A P A G G G G P S V V T A I A I M A L Y S V V C V V - - G L F G N F L V M Y V I I R - 
X.Trop - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - R - 
Z.fish - N S S V C D R T P E L D K S S T P V I V A I I I T A L Y S I V C V M G M G L V G N V L V M Y V I I R - 
LR DG - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
I 
 
                                                    
Human - - - - M K T A T N I Y I F N L A L A D A L A T S T L P F Q S V N Y L M G T W P F G T I L C K I V I S - 
Chicken - Y T K M K T A T N I Y I F N L A L A D A L A T S T L P F Q S V N Y L M G T W P F G T I L C K I V I S - 
X.Trop - Y T K M K T A T N I Y I F N L A L A D A L A T S T L P F Q S V N Y L M G T W P F G N I V C K I V I S - 
Z.fish - Y T K M K T A T N I Y I F N L A L A D S L A T S T L P F Q S V N Y L M G T W P F G D E L C K I V M S - 




                                                    
Human - I D Y Y N M F T S I F T L C T M S V D R Y I A V C H P V K A L D F R T P R N A K I I N V C N W I L S - 
Chicken - I D Y Y N M F T S I F T L C T M S V D R Y V A V C H P V K A L D F R T P R N A K I V N V C N W I L S - 
X.Trop - I D Y Y N M F T S I F T L T T M S V D R Y I A V C H P V K A L D F R T P R N A K I V N V C N W I L S - 
Z.fish - I D Y Y N M F T S I F T L T T M S V D R Y I A V C H P V K A L D F R T P R N A K I V N V C N W I L S - 




                                                    
Human - S A I G L P V M F M A T T K - - - Y R Q G S I D C T L T F S H P T W Y W E N L L K I C V F I F A F I - 
Chicken - S A I G L P V M F M A T T K - - - Y R Q G S I D C T L T F S H P A W Y W E N L L K I C V F I F A F I - 
X.Trop - S A I G L P V M F M A T T K - - - S E R G S T D C A L L F P H P S W Y W D N L L K I C V F I F A F I - 
Z.fish - S A I G L P V M V M A S T T S D L H S N G I I D C T L L F P H P S W Y W E N L L K I C V F I F A F I - 




                                                    
Human - M P V L I I T V C Y G L M I L R L K S V R M L S G S K E K D R N L R R I T R M V L V V V A V F I V C - 
Chicken - M P V L I I T V C Y G L M I L R L K S V R M L S G S K E K D R N L R R I T R M V L V V V A V F I I C - 
X.Trop - M P V L I I T V C Y G M M I L R L K S V R M L S G S K E K D R N L R R I T R M V L V V V A V F I V C - 
Z.fish - M P V L I I T V C Y G L M I L R L K S V R M L S G S K E K D R N L R R I T R M V L V V V A V F I V C - 




                                                    
Human - W T P I H I Y V I I K A L V T I P E T T F Q T V S W H F C I A L G Y T N S C L N P V L Y A F L D E N - 
Chicken - W T P I H I Y V I I K A L V N I P E T T F Q T V S W H F C I A L G Y I N S C L N P V L Y A F L D E N - 
X.Trop - W T P I H I Y V I I K A L I N I P P S L F Q T V T W H V C I A L G Y T N S C L N P V L Y A F L D E N - 
Z.fish - W T P I H I F V I I K A L V T I P N S L L Q T I T W H F C I A L G Y T N S C L N P V L Y A F L D E N - 





TM V TM VI 
TM VII 
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Figure 15 MOR vertebrate alignment: Each animal was aligned using ClustalW and 
only the conserved regions for all five groups are shaded in gray. (-) represent gaps 
inserted where no base is present. The vertebrate sequences for human, chicken, Xenopus 
tropicalis, and zebrafish can be found in the NCBI database using the accession 
numbers/protein ID’s: NM_000914.3, ENSGALP00000022114, 















The horn shark (HS) fragment shows a great deal of conservation with the DOR’s 
vertebrates (Figure 18). Although the phylogenetic analysis could not determine if it was 
more delta-like or mu-like, the vertebrate alignment shows that it shares a high mount of 
sequence identity with all of the vertebrates. Within the most conserved region, the 
intracellular loops, the HS fragment shares 94% sequence identity with both newt and 
zebrafish. The transmembrane regions show sequence identities ranging from 77-90% 
and even the extracellular loops show sequence identities as high as 73% in human and 
chicken. Overall sequence identities ranging from 80-86% show that the horn shark 
fragment is most similar to the DOR (Table 6). 
The sturgeon ORL-fragment turned out to be less conserved than the KOR 
fragment with an overall sequence identity ranging from 73-80% within the partially 
cloned 201 amino acid residue region (Figure 20).  The extracellular loops are poorly 
conserved with as low as 43% sequence identity in newt, 52% identity in human and 
chicken, and 67% in zebrafish. The transmembrane domains and intracellular loops are 
the most highly conserved with amino acid identities ranging from 74%-94%. Overall, 
the zebrafish again shares the most sequence identity with white sturgeon ORL fragment 


















 Human Chicken Newt Zebrafish 
ICL’s 90% 86% 92% 92% 
ECL’s 58% 56% 56% 49% 
TM’s 69% 71% 72% 72% 




Table 4 LR 1A Amino Acid % Identity:  This table shows the amino acid % identities 
of the intracellular loops (ICL), extracellular loops (ECL), and transmembrane domains 
(TM) for only the partial (191 residues) amino acid fragment cloned. Amino acid % 
identities are present for human, chicken, Xenopus tropicalis (X.trop), and zebrafish. 
Percent identities include the gaps inserted during the multiple sequence alignment 












Table 5 LR 1B & 2B Amino Acid % Identity:  This table shows the amino acid % 
identities of the intracellular loops (ICL), extracellular loops (ECL), and transmembrane 
domains (TM) for only the partial (88 residues for 1B and 111 residues for 2B) amino 
acid fragment cloned. Amino acid % identities are present for human, chicken, xenopus 
tropicalis (x.trop), and zebrafish. Percent identities include the gaps inserted du ing the 
multiple sequence alignment performed by ClustalW. 
 
 








 Human Chicken Newt Zebrafish 
ICL’s 88% 85% 88% 92% 
ECL’s 61% 61% 61% 61% 
TM’s 91% 93% 87% 86% 
Overall 84% 84% 83% 83% 








 Human Chicken Newt Zebrafish 
ICL’s 96% 96% 88% 88% 
ECL’s 67% 67% 67% 67% 
TM’s 87% 87% 91% 85% 
Overall 86% 86% 86% 82% 
55 
Chicken      M D P L F P A H I L E D P D L R K L L N D S S M L N - - L S F L P S N W F N N G T G D S F L P L S I 
Newt M D P H F S I P S F E A S Y L S K L L N D S S V M N - - L S T L P S G W Y F N S T S D T F L P L G I 
Human M E P L F P A P F W E V I Y G S H L Q G N L S L L S P N H S L L P P H L L L N A S H G A F L P L G L 
Z.fish M E - - F P N D S I G F T D P R H F H - - - - L Y N - - E S L F Q N N F S T F N E S D S F F P K G F 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
I 
 
                                                    
Chicken K I T I V V V Y S I V C I V G L V G N C S V M Y V I V R F T K M K T A T N I Y I F N L A L A D T L C 
Newt K L T I V I V Y L I V C V L G L V G N C A V M F V I V R Y T K M K T A T N I Y I F N L A L A D A L V 
Human K V T I V G L Y L A V C V G G L L G N C L V M Y V I L R H T K M K T A T N I Y I F N L A L A D T L V 
Z.fish K I T I A V V Y M I V C V V G L V G N C L V M Y V I I R Y T K M K T A T N I Y I F N L A L A D A L V 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - K T A T N I Y I F N L A L A D F L V 
 
I                                                   
Chicken L M T L P F Q G T D T F L G F W P F G N V L C K I A I S I D Y Y N M F T S T F T L T M M S V D R Y I 
Newt L V T L P F Q G T D T F L G F W P F G N V L C K I A I A I D Y Y N M F T S T F T L T M M S V D R Y I 
Human L L T L P F Q G T D I L L G F W P F G N A L C K T V I A I D Y Y N M F T S T F T L T A M S V D R Y V 
Z.fish L A T L P F Q G T D V F L G F W P F G N A L C K V V V S I D Y Y N M F T S V F T L T V M S M D R Y V 
Sturgeon L L T L P F Q G T D V F L G S W P F G K L L C K I V I A I D Y Y N M F T S T F T L T M M S V D R Y I 
I 
 
                                                  
Chicken A I C H P I K A L D I R T P H K A K V V N V C I W A L A S V F G I P A M V M G S A E N E - - N N E I 
Newt A I C H P V K A L D I R T P H K A K I I N V C I W A L A S V I G V P V M V M G S A E M E - - N N E V 
Human A I C H P I R A L D V R T S S K A Q A V N V A I W A L A S V V G V P V A I M G S A Q V E - - D E E I 
Z.fish A V C H P V K A L D M R T P H K A K V V N I C V W V L A S A I G V P A M V L G D V E Q D - N G E S I 
Sturgeon A V C H P V K A L D M R T P H K A K V V N I C I W A L A S V I G I P A M V M G D V E E D P Y G T A I 
I 
 
                                                  
Chicken D C L I K L P S P V D Y W D P V F G I C V F L F S F M I P V L I I T I C Y S L M I R R L K N V R V L 
Newt E C L V Q I P V P E D Y W D P V F G I C V F V F S F V I P V F I I T I C Y S L M I R R L K N V R V L 
Human E C L V E I P T P Q D Y W G P V F A I C I F L F S F I V P V L V I S V C Y S L M I R R L R G V R L L 
Z.fish E C I L V L P D P R S Y W D P V F G T C V F L L S F L I P V A I I S V C Y S L M V K R L R S V R I L 
Sturgeon E C A V V L P Q P C S F C D A V F G T C V F I F S F V V P V A I I T I C Y T L M V K R L K N V R V L 
I 
 
                                                  
Chicken S G S K E K D R N L R R I T R M V L V V V A V F I I C W T P I Q I F V L V Q C L G A K A E S E L E L 
Newt S G S K E K D R N L R R I T R L V L V V V A V F V I C W T P I Q I F V L V Q C L G A K P D S E A K V 
Human S G S R E K D R N L R R I T R L V L V V V A V F V G C W T P V Q V F V L A Q G L G V Q P S S E T A V 
Z.fish S G S K E K D R N L R R I T R M V L V V V A A F V V C W T P I Q I M A L A Q S L G F N L A S V Q T V 
Sturgeon S G S K E K D R M L R R I T R M V L I V V A V F V V C W T P I Q I - - - - - - - - - - - - - - - - - 
I 
 
                                                  
Chicken A I S C F C T A L G Y A N S S L N P V L Y A F L D E N F K A C F K K F C F P T A F R T E L Q M S N R 
Newt V I L H F C I A L G Y V N S S L N P I L Y A F L D E N F K A C F R K F C F P A A F R S E L Q M S N R 
Human A I L R F C T A L G Y V N S C L N P I L Y A F L D E N F K A C F R K F C C A S A L R R D V Q V S D R 
Z.fish V F M H F C I A L G Y V N S S L N P V L Y A F L D E N F K R C F R E F C H P S R F G I D A Q Q S G R 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
I                                                   
Chicken M C S I A K D V A Y A C K N S E G T N N P A                             
Newt M C S I A K D V A Y A C K N S D G T N N P A                             
Human V R S I A K D V A L A C K T S E T V P R P A                             
Z.fish M R H I T R E V A F N C K T T D G N S N P A                             
Sturgeon - - - - - - - - - - - - - - - - - - - - - -                             
I                                                   
 
















Figure 16 ORL vertebrate alignment: Each animal was aligned using ClustalW and 
only the conserved regions for all five groups are shaded in gray. (-) represent gaps 
inserted where no base is present. The vertebrate sequences for human, chicken, rough-
skinned newt, and zebrafish can be found in the NCBI database using the accession 





























Table 6 HS DOR Amino Acid % Identity: This table shows the amino acid % identities 
of the intracellular loops (ICL), extracellular loops (ECL), and transmembrane domains 
(TM) for only the partial (202 residues) amino acid fragment cloned. Amino acid % 
identities are present for human, chicken, Xenopus tropicalis (X.trop), and zebrafish. 
Percent identities include the gaps inserted during the multiple sequence alignment 












 Human Chicken Newt Zebrafish 
ICL’s 92% 94% 90% 94% 
ECL’s 73% 73% 71% 69% 
TM’s 77% 88% 90% 82% 
Overall 80% 86% 86% 82% 
58 
 
Chicken - M D A - P V Q I F R E E L D S T C M P G P C R P S S T S S S W P L G W A D Y D S N A T G T F R D T Q - 
Human - M D S - P I Q I F R G E P G P T C A P S A C L P P - N S S A W F P G W A E P D S N G S A G S E D A Q - 
X.Trop - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Z.fish - M D S N V V Q I F K E D K C P S S H P E K C L P N - - - F T W Q S - - A V S D I Y N S S L N E S W T - 




                                                   
Chicken - H N S T S I S P S I P I I I T A V Y S V V F V V G L V G N S L V M F V I I R Y T K M K T A T N I Y I - 
Human - L E P A H I S P A I P V I I T A V Y S V V F V V G L V G N S L V M F V I I R Y T K M K T A T N I Y I - 
X.Trop - - - - - - - - - - - - - I I T A V Y S M V F V V G L V G N A L V M F V I I R Y T K M K T A T N I Y I - 
Z.fish - T E Q E A M S P L I P - I I T A V Y S V V F V V G L V G N C L V M Y V I I R H T K M K T A T N I Y I - 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - K T A T N I Y I - 
I 
 
                                                    
Chicken - F N L A M A D A L V T T T M P F Q S T E Y L M N S W P F G D V L C K I V I S I D Y Y N M F T S I F T - 
Human - F N L A L A D A L V T T T M P F Q S T V Y L M N S W P F G D V L C K I V I S I D Y Y N M F T S I F T - 
X.Trop - F N L A L A D A L V T T T M P F Q S T S F L M N S W P F G D V L C K I V V S I D Y Y N M F T S I F T - 
Z.fish - F N L R V A D A L V T T T M P F Q S T D Y L L N S W P F G E V V C K V F I S I D Y Y N M F T S I F T - 
Sturgeon - F N L A V A D A F V T T T M P F Q S T D Y L L G T W P F G E V V C K I F I S I D Y Y N M F T S I F T - 
I 
 
                                                    
Chicken - L T M M S V D R Y I A V C H P V K A L D F R T P L K A K I I N I C I W L L S S S V G I S A I V L G G - 
Human - L T M M S V D R Y I A V C H P V K A L D F R T P L K A K I I N I C I W L L S S S V G I S A I V L G G - 
X.Trop - L T M M S V D R Y I A V C H P V K A L D F R T P L K A K C I N I C I W M L S S S V G I S A I V L G G - 
Z.fish - L T M M S V D R Y V A V C H P V K A L D F R T P M K A K I I N I L I W V L S S A A G I P A M V L G S - 
Sturgeon - L T M M S V D R Y I A V C H P V K A L D F R T P V K A K I I N V C I W I L S S A A G I P A L I L G S - 
I 
 
                                                    
Chicken - T K V R E D T G S T E C S L Q F P D R D Y V W W D I F M K I C V F V F A F V I P V L I I I V C Y T L - 
Human - T K V R E D V D V I E C S L Q F P D D D Y S W W D L F M K I C V F I F A F V I P V L I I I V C Y T L - 
X.Trop - T K I S D A H G S T E C A L Q F P - T H Y W Y W D T V M K M C V F I F A F I I P V F I I T I C Y T L - 
Z.fish - T Q T - - N N G T T E C A L Q F P - D P Y V Y W D T L M K I C V F I F G F V A P L L I I T V C Y T L - 
Sturgeon - T E T - - N H G T T E C A L Q F P - E P Y V Y W D T L M K I C V F I F A F V V P V L I I T V C Y T L - 
I 
 
                                                    
Chicken - M I L R L K S V R L L S G S R E K D R N L R R I T R L V L V V V A V F I I C W T P I H I F V L V E A - 
Human - M I L R L K S V R L L S G S R E K D R N L R R I T R L V L V V V A V F V V C W T P I H I F I L V E A - 
X.Trop - M I L R L K S V R L L S G S R E K D R N L R R I T R L V L V V V A V F I V C W T P I H I F V L V E A - 
Z.fish - M V L R L K S V R L L S G S R E K D R N L R R I T R L V L V V V A V F V V C W T P I H I F I L V K A - 
Sturgeon - M I L R L K S V R L L S G S R E K D R N L R R I T K L V L V V V A V F I I C W T P I H I - - - - - - - 
I 
 
                                                    
Chicken - L G D - V S H S T A A V S S Y Y F C I A L G Y T N S S L N P I L Y A F L D E N F K R C F K D F C F P - 
Human - L G S - T S H S T A A L S S Y Y F C I A L G Y T N S S L N P I L Y A F L D E N F K R C F R D F C F P - 
X.Trop - L V D - V P Q S I A V V S I Y Y F C I A L G Y T N S S L N P I L Y A F L D E N F K R C F K - - - - - - 
Z.fish - L S H G V P E T T S V M A A Y F F C V A L G Y T N S S L N P I L Y A F L D E N F K R C F R D F C C P - 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
I                                                     
Chicken - F K M R M D R Q S T S R V R N T V Q D - - - P A Y R R E A D G T N K P V               - 
Human - L K M R M E R Q S T S R V R N T V Q D - - - P A Y L R D I D G M N K P V               - 
X.Trop - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -               - 
Z.fish - G R T A G D G R G V S R V R S T L R E H T C P A E A K N D G G Q G R P V               - 
Sturgeon - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -               - 
TM I 
TM I I  TM III 
ICL 1 
ECL 1 
TM IV ICL 2 
TM V ECL 2 
TM VI ICL 3 










                                                    
Figure 17 KOR vertebrate alignment: Each animal was aligned using ClustalW and 
only the conserved regions for all five groups are shaded in gray. (-) represent gaps 
inserted where no base is present. The vertebrate sequences for human, chicken, xenopus 
tropicalis, and zebrafish can be found in the NCBI database using the accession 

































Table 7 WS ORL/KOR Amino Acid % Identity:  This table shows the amino acid % 
identities of the intracellular loops (ICL), extracellular loops (ECL), and transmembrane 
domains (TM) for only the partial (201 residues for ORL and 199 residues for KOR) 
amino acid fragment cloned. Amino acid % identities are present for human, chicken, 
Xenopus tropicalis (X.trop), and zebrafish. Percent identities include the gaps inserted 
during the multiple sequence alignment performed by ClustalW. 
 









 Human Chicken Newt Zebrafish 
ICL’s 74% 92% 94% 90% 
ECL’s 52% 52% 43% 67% 
TM’s 82% 82% 79% 79% 
Overall 73% 78% 75% 80% 









 Human Chicken X.Trop Zebrafish 
ICL’s 96% 96% 95% 94% 
ECL’s 51% 57% 62% 83% 
TM’s 87% 87% 82% 89% 
Overall 81% 82% 81% 89% 
61 
KOR receptors appear to be highly conserved among vertebrates (Figure 21) 
showing 81-89% overall sequence identity within the partially cloned sturgeon regi
(202 amino acid residues including gaps). The intracellular loops provide the highest 
amino acid identity ranging from 94% with zebrafish to 96% with chicken and human. 
The extracellular loops are the most divergent with sequence identities as low  51% 
with human to sequence identities as high as 83% with zebrafish.  The transmembrane 
domains are also highly conserved among all vertebrates with 82-89% sequence identity. 
As expected, zebrafish shows the highest overall sequence identity with white sturg on 
because of its close evolutionary position to sturgeon with 89% overall identity (Table 7). 
Human, chicken, and Xenopus tropicalis all share approximately the same overall
sequence identity with sturgeon.  
Although the vertebrate alignments, amino acid percent identity tables, and the 
BLAST searches provided substantial evidence for the identity of each cloned fragment, 
phylogenetic analyses were performed to add further support and confirmation of hese 
results. 
 
F. Phylogenetic Analysis 
 The cloned fragments were further compared using an exhaustive search mode of 
the maximum parsimony algorithm (PAUP 4.1). Each clone was analyzed with all four 
zebrafish receptors to elucidate their evolutionary order and further confirm which 
receptor, from the species presented in Section E, each fragment is most closely align d. 
Lamprey somatostatin (LRSS) was used as the outgroup because this receptor is also a 
member of the Rhodopsin family of G-Protein coupled receptors and Blast P indicates 
62 
that somatostatin receptors have the highest sequence identity to opioid receptors. 
Somatostatin receptors are encoded on intron-less genes and were used by Li et al. (1996) 
as the group for their seminal study on opioid-related receptors in the hagfish brain. To 
test the robustness of each phylogenetic tree, a bootstrap analysis was performed using 
1000 replicates and a confidence level for each clade that was present within each tre  
was assigned. Bootstrapping is a technique that resamples the original data set a number 
of times to see if the outcome (most parsimonious tree) remains the same. The bootstrap 
value represents how many times the resampled data support the original most 
parsimonious tree (Graur and Li, 1999). 
 The phylogenetic analysis showed that the lamprey DG (LR DG) fragment was 
most closely related to zebrafish MOR (ZMOR) with a confidence level of only 50%.
The tree shows that ZMOR and LR DG are sister taxa that are connected to the Zebrafish 
DOR (ZDOR) with 93% confidence level. This means that 93% of the trees created by 
resampling the data 1000 times through bootstrapping, support this clade. Zebrafish KOR 
(ZKOR) and ORL (ZORL) do not share a clade with the LR DG fragment but are related 
to one another. Overall the phylogenetic study suggests that LR DG is most closely 



























Figure 18 a-b: Phylogenetic analysis of lamprey DG and lamprey 1A based only on the 
partial fragment size (204 and 191 amino acid residues respectively). Each lamprey 
species was compared to all four zebrafish opioid/orphanin receptors using somatostatin 
as an outgroup. Each phylogenetic tree was created using the phylogenetic analysis using 
parsimony (PAUP). A boostrap value for each clade within each tree was assigned based 





















The tree produced for the lamprey 1A (LR 1A) fragment shows that its most 
closely related to ZDOR with a 76% confidence level. LR 1A and DOR are sister taxa 
that are connected to, but separate from, ZMOR with a 96% confidence level. ZKOR is 
equally related to ZDOR, LR 1A, and ZMORT with a 97% confidence level. ZORL is the 
most divergent from 1A and the closest to ZKOR (Figure 14b). 
The phylogenetic analysis for the lamprey 1B (LR 1B) fragment presents a simple 
relationship. The LR 1B fragment cannot be distinguished as being more delta or mu-like 
possibly due to its smaller fragment size (88 amino acid residues). Therefore, all three 
receptors share a clade as sister taxa with an 80% confidence level. They are connected to 
the ZKOR with a 68% confidence level and again are most divergent from the ZORL. 
The LR 1B fragment could be considered as either a delta or mu variant (Figure 15a). 
The lamprey 2B (LR 2B) fragment does not show a clear relationship to either 
ZDOR or ZMOR. The tree shows that ZDOR and ZMOR are sister taxa with an 86% 
confidence level. They do share a clade with 2B showing that they are related but that 
they branched off separately with an 86% confidence level. The LR 2B fragment also 
shares a clade with the ZKOR fragment expressing a 76% confidence level. ZORL is 
again the most divergent from ZDOR, ZMOR, and LR 2B (Figure 15b). 
The horn shark DOR (HS DOR) fragment shows a similar relationship as the LR 
1B fragment. The relationship between delta and mu is not clear and therefore, the HS 
fragment is a sister taxa of both receptors sharing a clade with 97% confidence. Although 
the initial nucleotide BLAST showed that the sequence was more delta-like, the 
phylogenetic analysis suggests that it may be a delta or mu variant (Figure 16).  
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Figure 19 a-b: Phylogenetic analysis of lamprey 1B and lamprey 2B based only on the 
partial fragment size (88 and 111 amino acid residues respectively). Each lamprey 
species was compared to all four zebrafish opioid/orphanin receptors using somatostatin 
as an outgroup. Each phylogenetic tree was created using the phylogenetic analysis using 
parsimony (PAUP). A boostrap value for each clade within each tree was assigned based 



































Figure 20: Phylogenetic analysis of the horn shark fragment based only on the partial 
fragment size (200 amino acid residues respectively). The horn shark was compared to all 
four zebrafish opioid/orphanin receptors using somatostatin as the outgroup. Each 
phylogenetic tree was created using the phylogenetic analysis using parsimony (PAUP). 
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 The white sturgeon ORL (WS ORL) fragment is the only receptor in the tree that 
is connected to the ZORL indicating that WS ORL is most similar to ZORL. The WS 
ORL is also not connected to ZDOR or ZMOR, but it is connected to ZKOR with a 69% 
confidence level. The lack of relatedness between ORL with any of the other receptors 
represents the evolutionary divergence that is present between ORL with DOR and MOR. 
As expected, the ZDOR and ZMOR are sister taxa sharing a clade with 98% confidence 
(Figure 17a). 
 The phylogenetic tree created for white sturgeon KOR (WS KOR) starts to unveil 
the classic relationship between the opioid/orphanin receptors. The ZDOR and ZMOR
are sister taxa sharing a clade with 80% confidence. The WS KOR fragment and the 
ZKOR also represent sister taxa with a relatively high confidence level of 95%. The tree 
confirms with 100% confidence that each clade of sister taxa branched in this exact order 
(Figure 17b).   






























Figure 21 a-b: Phylogenetic analysis of sturgeon ORL and KOR based only on the 
partial fragment size (201 and 199 amino acid residues respectively). Each sturgeon 
species was compared to all four zebrafish opioid/orphanin receptors using somatostatin 
as an outgroup. Each phylogenetic tree was created using the phylogenetic analysis using 
parsimony (PAUP). A boostrap value for each clade within each tree was assigned based 





















 To complete the evolutionary scheme between all vertebrates, each animal was 
further compared to expose their evolutionary relationship using a heuristic search mode 
of the maximum parsimony algorithm (PAUP 4.1). An exhaustive search with bootstrap 
values was too rigorous for the algorithm’s capabilities. The evolutionary reltionship 
between opioid/orphanin receptors is clearly laid out in the final phylogenetic tree. It 
plainly shows that ORL’s are the most divergent from every other receptor except 
KOR’s. DOR’s and MOR’s are most closely related to each other and only distantly 
related to ORL’s through the KOR’s.  
The LR 2B fragment is connected to the clade that splits MOR’s and DOR’s 
meaning that it is indistinguishable as either but is directly related to both. The LR DG 
and LR 1B fragments are most similar to each other and most closely related to th  
MOR’s, which presented a great evolutionary stair step: lamprey → zebrafish → xenopus 
tropicalis → chicken → human. The LR 1A fragment and the HS fragment are most 
similar to the DOR’s which, for the most part, also provide a classic evolutionary 
pathway: lamprey → zebrafish → horn shark → xenopus tropicalis → human → chicken. 
The glue that holds the opioid/orphanin receptor family together seems to be the KOR’s 
because they are directed related to both the DOR/MOR group and to ORL’s. The WS 
KOR is most similar to the ZKOR, and the group follows the pattern: white sturgeon → 
zebrafish → xenopus tropicalis → human → chicken. The ORL’s are a little more 
confusing showing the WS ORL being directly connected to the KOR cluster and the 
ZORL. Overall, it clear that ORL is the most distant receptor directly related to only 
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Figure 22 Vertebrate Phylogenetic Tree: Phylogenetic analysis of all four 
opioid/orphanin receptors using somatostatin (LRSS) as an outgroup. Each phylogenetic 
tree was created by a heuristic search using the phylogenetic analysis using parsimony 
(PAUP). Each species is abbreviated as follows: Human = H, Chicken = C, Newt = N, 
Xenopus tropicalis = X, Zebrafish = Z, White Sturgeon = WS, Horn shark = HS, and 



















 Because the opioid/orphanin gene family are members of the G protein-coupled 
super family they are highly structurally conserved. They all share common structural 
characteristics that serve specific functions. All members of the G protein-coupled 
receptor superfamily share an extracellular N-terminal, intracellular C-terminal and seven 
transmembrane domains. Within the opioid receptor family, there are also other 
conserved regions that seem to elucidate receptor functionality and ligand binding. I  
mammalian opioid receptors, the highest conservation lies within the transmembran  
domains and intracellular loops accounting for 42-76% (excluding TM4) and 59-89%  
receptor identity, respectively (Tables 3-7). This vast conservation among the 
opioid/orphanin gene family is believed to be a result of whole genome duplication. The 
most divergences among mammalian opioid receptors exist within the extracellular loops, 
which has led researchers to propose that these extracellular loops are significant i  
ligand selectivity. The zebrafish has been the only fish available with full sequence 
identity for each of the four receptors. Therefore, by cloning extant representatives from 
early vertebrates such as the lamprey, horn shark, and white sturgeon, it becomes more 
evident when these genome duplications took place and offers more insight about the 
ancient structural similarities that these receptor share. 
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1. Ligand/Receptor Binding 
 The vertebrate protein alignments revealed that all of the cloned receptor 
fragments demonstrate 71-91% sequence identity among transmembrane domains fr  
jawless fish to mammals (Tables 3-7).  This high conservation between transmembrane 
domains in opioid/orphanin receptors has been shown to be responsible for ligand 
binding. Opioid/orphanin receptors have seven transmembrane domains that are believed 
to be tightly associated within the membrane and folded into a helical bundle with an 
internal aromatic binding pocket. Using three-dimensional computer modeling of the 
DOR, the  opioid binding pocket was shown to span across TM III through TM VII. 
Critical residues within this aromatic pocket include tyrosine, phenylalanine, and 
tryptophan residues. Site-directed mutagenesis of these critical aromatic residues has 
been shown to dramatically affect ligand binding (Befort et al., 1996). The residues 
within the aromatic pocket are highlighted in Figure 23. Reviewing the transmembrane 
regions in the cloned receptor fragments revealed that the most divergent transmembrane 
region within all of the vertebrate alignments was undoubtedly TM IV with only seven 
conserved regions. The tryptophan residue found within this transmembrane region is one 
of the critical aromatic residues found within the opioid binding pocket. It is conserved 
not only in every cloned receptor fragment, but also in all four vertebrates used in th  
alignments and all four receptors. In fact, all of the cloned receptor fragments, although 
presented over three different vertebrate classes, display conservation among these 
critical aromatic residues suggesting that they are indeed very significant in opioid 






Figure 23: Schematic depiction of the opioid/orphanin receptor structure. Seven 
transmembrane spanning domains with highlighted amino acids representing the critical 






2. Ligand/Receptor Selectivity 
The most divergent regions within the opioid receptors lie within the extracellular 
loops. Chimeric µ/κ and κ/δ receptors have revealed which extracellular loops are 
important within each receptor for ligand selectivity. It has been shown that ECL2 and 
the top of TM4 are involved in kappa selectivity, ECL3 is involved with delta selectivity, 
and ECL2 and ECL3 are responsible for mu selectivity (Jordan et al., 1998). The second 
extracellular loop is also important in ORL selectivity due to its highly negative charge, a 
characteristic it shares with the kappa extracellular loop. The KOR vertebrate alignment 
highlights only twelve conserved amino acid residues within ECL2 giving it the highest 
sequence identity between all of the ECL’s in all of the receptors at 41% (Figure 24a). 
The alignment for MOR shows that the second and third extracellular loops are highly 
divergent among vertebrates including the newly cloned LR DG fragment. Only nine 
residues remain conserved within ECL2 resulting in 31% sequence identity, and seve 
residues for ECL3 resulting in 27% sequence identity (Figure 24b). The third 
extracellular loop is significant for DOR, and the alignment shows that only four amino 
acid residues are conserved within ECL3 exhibiting only 23% sequence identity (Figure 
24c). The second extracellular loop in ORL shows the highest amount of divergence with 
only four amino acid residues conserved and only 14% sequence identity (Figure 24d). 
Because these regions are so divergent, the conserved residues must play an importat 
role in opioid/orphanin selectivity. The disulfide bridge between EC1 and EC2 is also 
conserved within all the receptors cloned from lamprey, horn shark, and white sturgeon. 
This further confirms the importance of these residues in stabilizing the functional 
receptor protein. 
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In 1996 Meng and colleagues took full advantage of the divergence within the 
extracellular loops in a quest to discover which amino acid residues play a role in ligand 
selectivity. They used the Orphanin FQ (ORL-1) receptor due to its lack of binding 
capabilities with any other classic opioid ligand. Their goal was to give the Orphanin FQ 
receptor the potential to bind opioid ligands through changing critical amino acids. By 
altering just four amino acid residues, the receptor was transformed into a kappa-li e 
receptor capable of binding κ-selective opioids. However, intolerance for the other 
endogenous opioids still persisted (Meng et al., 1996). The phylogenetic analyses provide 
insight as to why this situation might exist. The ORL receptor did not show any direct 
relationship to the delta or the mu receptor in any of the phylogenetic trees including the 
last tree which helped to solidify the relationship among these receptors.. It appears that 
the ORL receptor is very distantly related to the delta and mu receptors. Because there is 
such a distinct relationship between ORL with KOR and DOR with MOR, the mystery 
















(a). Vertebrate KOR ECL 2 










































Chicken - T K V R E D T G S T E C S L Q F P D R D Y V W W D I F M K 
Human - T K V R E D V D V I E C S L Q F P D D D Y S W W D L F M K 
X.Trop - T K I S D A H G S T E C A L Q F P - T H Y W Y W D T V M K 
Z.fish - T Q T - - N N G T T E C A L Q F P - D P Y V Y W D T L M K 
Sturgeon - T E T - - N H G T T E C A L Q F P - E P Y V Y W D T L M K 
Human    - T K - - - Y R Q G S I D C T L T F S H P T W Y W E N L L K 
Chicken - T K - - - Y R Q G S I D C T L T F S H P A W Y W E N L L K 
X.Trop - T K - - - S E R G S T D C A L L F P H P S W Y W D N L L K 
Z.fish - T T S D L H S N G I I D C T L L F P H P S W Y W E N L L K 
Lamprey - I K P - - D Q I G Y M E C L V V F P Q P P W F W E T L L K 
Human     - W T P I H I Y V I I K A L V T I P E T T F Q T V S W 
Chicken - W T P I H I Y V I I K A L V N I P E T T F Q T V S W 
X.Trop - W T P I H I Y V I I K A L I N I P P S L F Q T V T W 
Z.fish - W T P I H I F V I I K A L V T I P N S L L Q T I T W 




   W T L V D I D R R D P LVVAAL     
   W T L V D I D K K N P YVVASL 
   W T M V D I D K K N P FVIASW 







(d). Vertebrate ORL ECL 2 
 
 
Chicken    AENE--NNEIDCLIKLPSPVDYWDPVFGI 
Newt       AEME--NNEVECLVQIPVPEDYWDPVFGI 
Human      AQVE--DEEIECLVEIPTPQDYWGPVFAI 
Z.fish     VEQD-NGESIECILVLPDPRSYWDPVFGT 





Figure 24 ECL’s in Vertebrate Alignments: Vertebrate amino acid alignments of 
extracellular loops for each receptor. Sequences were aligned using ClustalW and shaded 












3. Genome Duplication 
 The high conservation that exists between MOR and DOR versus KOR and ORL-
1 may be a result of two whole genome duplications (WGD). In 1970 Susumu Ohno 
came forth with his 2R hypothesis which proposed that the vertebrate genome was 
exposed to two rounds of WGD.  A genome duplication was thought to take place after 
the introduction of urochordates such as the tunicate, but before the radiation of jawed 
vertebrates. When a genome duplication occurs, one copy of the gene retains 
functionality while the second copy is free from selective pressure to maintain the same 
function and can therefore evolve new functions. The HOX gene family provides 
evidence for the 2R hypothesis in cephalochordates and mammals. In amphioxus there is 
a single HOX cluster while humans have a cluster of four HOX genes all of which are 
located on different chromosomes (reviewed in Kasahara 2007). If this gene family was 
duplicated by a single gene duplication event, the ancestral gene and all of its derived 
genes would reside on the same chromosome. However, when the entire genome is 
duplicated, the new set of chromosomes is subject to mutations, translocations, 
chromosomal rearrangement and deletions. Both the ligands and receptors of the 
opioid/orphanin gene family exhibit patterns of WGD. 
 The four opioid/orphanin ligands, enkephalin, dynorphin, orphanin, and β-
endorphin, are encoded by four different precursors, proenkephalin, prodynorphin, 
proorphanin, and proopiomelanocortin (POMC) respectively. It is believed that these four 
precursors evolved from a single ancestral proenkephalin-like gene through successive 
duplication events. Each duplication event is thought to give rise to two copies of the pro-
enkephalin-like gene. One copy would retain its original proenkephalin-like function 
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while the other copy either became a pseudo gene or a novel gene. The ancestral 
proenkephalin-like gene first gave to POMC, the proorphanin, and finally prodynorphin. 
The duplication events are outlined in Figure 25 (reviewed in Dores et al., 2002). The 
protochordate duplication gave rise to proorphanin and the agnathan duplication gave rise 
to the most recent precursor, prodynorphin. Since prodynorphin arose after the agnathan 
duplication, it should not be present within the jawless vertebrates. However, this study 
reveals that prodynorphin is in fact present within the lamprey. As the lamprey genome 
was probed with a proenkephalin sequence, a prodynorphin sequence was pulled out. 
That sequence was used to design primers and a portion of the lamprey prodynorphin 
sequence was cloned. This portion included a part of dynorphin A and dynorphin B 
shown in Figure 26. Therefore, the evolutionary scheme presented in Figure 25 needs to 
be adjusted. It now appears more likely that the prodynorphin gene is ancestral to the 
proenkephalin gene. This begs the questions, what is the ancestral opioid gene, and do the 

















Figure 25: Proposed evolution of the opioid/orphanin gene family. Abbreviations:  



























                                                           *  *  [  
     1 CAGCAGCAGCAGCAACTGAACGGCATCGTCCTCCCATTCGGCGCGGTGGACAAACGCTAC 
     1 -Q--Q--Q--Q--Q--L--N--G--I--V--L--P--F--G--A--V--D--K--R--Y- 
                                                        
            α-Neoendorphin            ]  * 
    61 GGGGGCTTTGGAAGGGGCCGCTTTCGAACCAAGAGGGGGGAGCGCACCGAGGGGCGGGCG 
    21 -G--G--F--G--R--G--R--F--R--T--K--R--G--E--R--T--E--G--R--A- 
        
                          *  *  [          Dynorphin A 
   121 GATGGGAAGACCGTGCAGAAACGATACGGGGGCTTCATGCGGAGGGTGGGACGGCCGCAC 
    41 -D--G--K--T--V--Q--K--R--Y--G--G--F--M--R--R--V--G--R--P--H- 
 
                          ]  *  *  [         Dynorphin B 
   181 AAAGCGTCGTGGGCCAACCAGAAGCGCTACGGGGGGTTCATGCGCCGCTTCTTCGGTGTC 
    61 -K--A--S--W--A--N--Q--K--R--Y--G--G--F--M--R--R--F--F--G--V- 
                                                     
           ]  * 
   241 TCCATCCGCTCGGAGGACAGCGAAGGTCCCGCAGATAAGAGATTCAGCGCGTACGCTCGA 
    81 -S--I--R--S--E--D--S--E--G--P--A--D--K--R--F--S--A--Y--A--R- 
       
 
    
   301 CGCCGGCTCGTGCAGCAGTGA  + 503 UTR 




Figure 26 Lamprey Prodynorphin: Amino acid and nucleotide prodynorphin sequence 
pulled from the lamprey genome. The area where the primers were designed is underl ned 
and the cloned fragment is highlighted. The brackets enclose α-neoendorphin, dynorphin 
A, and dynorphin B respectively. The sequence can be found using the Contig 30377 in 
the Ensembl genome database  
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A study by Dreborg et al (2008) attempted to answer this question. They carried 
out phylogenetic analyses on the opioid receptor gene family and twenty neighborin 
gene families. Using relative dating, they found that the opioid receptors along with the 
neighboring gene families seem to have expanded in two tetraploidizations early in 
vertebrate evolution. The genomic regions that were analyzed in the Dreborg study share 
common evolutionary history in that they consist of quartets of chromosomes from each 
duplication event. This is why the opioid receptor gene family, along with the some of 
the other neighboring gene families consist of four members. The vertebrate opioid 
system was already relatively complex before the radiation of jawed vertebrates. Based 
on sequence identity, chromosomal location, and pharmacological studies, the mu and 
delta receptors are more closely related to each other and the kappa and ORL receptors 
are more closely related to each other (Dreborg et al., 2008). The receptors cloned in this 
study also support these findings both on a phylogenetic basis and on a sequence identity 
basis. Based on this, a proposed model for the evolution and divergence of the opioid 


































MOR DOR KOR ORL-1 
Ancestral Opioid/ORL-1 receptor 
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4. Future Studies 
 The initial steps in this study to clone opioid/orphanin receptors out of extant 
members of some of the oldest vertebrates is certainly a step in right direction, but to 
bring the characterization of these receptor sequences to completion, the 5’ and 3’ ends of 
each receptor need to be found. Each species should also be screened for any possibility 
of other opioid/orphanin receptors. It is interesting to note that the degenerate primer set 
used to pull out the LR DG, HS DOR, WS KOR, and WS ORL fragments were capable 
of pulling out any of the four opioid/orphanin receptors. However, the degenerate primer 
set repeatedly pulled out only delta-like and mu-like fragments with lamprey, delta-like 
fragments with horn shark, and kappa-like and ORL-like fragments with white sturgeon. 
This raises curiosity and highlights the significance about the existence of other 
opioid/orphanin receptors within these animals.  
 The lamprey prodynorphin cloning needs to be completed as well. Obtaining full 
length prodynorphin sequence within the lamprey will certainly change the evolutionary 
beliefs about the opioid/orphanin gene family in the science world. Cloning this crucial 
piece of the puzzle will provide evidence that may clear up questions raised around the 
order in which the opioid/orphanin ligands evolved. 
Cloning opioid/orphanin receptors out of lamprey, horn shark, and white sturgeon 
certainly provides insight about receptor structure but to fully understand how these new 
receptors contribute to this receptor family, binding studies should be undertaken to 
reveal the pharmacological profile of each new receptor. If all four of these receptors can 
be cloned and characterized from each species presented in this study, it would offer a 
great deal of information not only about the evolution of the receptors alone, but also the 
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co-evolution of the opioid/orphanin gene family as a whole. Provided with evolutionary 
knowledge about the opioid/orphanin receptors in non-mammalian vertebrates will help 
to better understand analgesic mechanisms in humans by identifying crucialamino acids 
that determine type selectivity of opioid analgesics. Using non-mammalian vertebrate 
models for analgesic research can be used to enhance the understanding of opioid drug 
selectivity (Stevens, 2008). Therefore, completing the cloning of the opioid/orphanin 
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